
<html lang="en"     class="pb-page"  data-request-id="533df2cc-7d21-4af2-a700-d03f4f90a2c3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-14;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00699;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane" /></meta><meta name="dc.Creator" content="Brian R.  Blank" /></meta><meta name="dc.Creator" content="Jiri  Gut" /></meta><meta name="dc.Creator" content="Philip J.  Rosenthal" /></meta><meta name="dc.Creator" content="Adam R.  Renslo" /></meta><meta name="dc.Description" content="We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of arterolane. Conformational analysis suggested that trans-3″-substitu..." /></meta><meta name="Description" content="We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of arterolane. Conformational analysis suggested that trans-3″-substitu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 10, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00699" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00699" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00699" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00699" /></link>
        
    
    

<title>Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00699" /></meta><meta property="og:title" content="Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0007.jpeg" /></meta><meta property="og:description" content="We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of arterolane. Conformational analysis suggested that trans-3″-substituted trioxolanes would exhibit Fe(II) reactivity and antiparasitic activity similar to that achieved with canonical cis-4″ substitution. The chiral 3″ analogues were prepared as single stereoisomers and evaluated alongside their 4″ congeners against cultured malaria parasites and in a murine malaria model. As predicted, the trans-3″ analogues exhibited in vitro antiplasmodial activity remarkably similar to that of their cis-4″ comparators. In contrast, efficacy in the Plasmodium berghei mouse model differed dramatically for some of the congeneric pairs. The best of the novel 3″ analogues (e.g., 12i) outperformed arterolane itself, producing cures in mice after a single oral exposure. Overall, this study suggests new avenues for modulating Fe(II) reactivity and the pharmacokinetic and pharmacodynamic properties of 1,2,4-trioxolane antimalarials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00699"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00699">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00699&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00699&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00699&amp;href=/doi/10.1021/acs.jmedchem.7b00699" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6400-6407</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00693" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00723" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+R.++Blank">Brian R. Blank</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiri++Gut">Jiri Gut</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+J.++Rosenthal">Philip J. Rosenthal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+R.++Renslo">Adam R. Renslo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pharmaceutical Chemistry and <sup>‡</sup>Department of Medicine, University of California San Francisco, 1700 Fourth Street, San Francisco, California 94158, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 415-514-9698; fax: 415-514-4507; e-mail: <a href="/cdn-cgi/l/email-protection#076663666a29756269746b68477264746129626372"><span class="__cf_email__" data-cfemail="ed8c898c80c39f88839e8182ad988e9e8bc3888998">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00699&amp;href=/doi/10.1021%2Facs.jmedchem.7b00699" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6400–6407</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 10, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 May 2017</li><li><span class="item_label"><b>Published</b> online</span>10 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00699" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00699</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00699"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1641</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00699" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;R. Blank&quot;},{&quot;first_name&quot;:&quot;Jiri&quot;,&quot;last_name&quot;:&quot;Gut&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;J. Rosenthal&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;R. Renslo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6400-6407&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00699&quot;},&quot;abstract&quot;:&quot;We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of arterolane. Conformational analysis suggested that trans-3″-substituted trioxolanes would exhibit Fe(II) reactivity and antiparasitic activity similar to that achieved with canonical cis-4″ substitution. The chiral 3″ analogues were prepared as single stereoisomers and evaluated alongside their 4″ congeners against cultured malaria parasites and in a murine malaria model. As predicted, the trans-3″ analogues exhibited in vitro antiplasmodial activity remarkably similar to that of their cis-4″ comparators. In contrast, efficacy in the Plasmodium berghei mouse model differed dramatically for some of the congeneric pairs. The best of the novel 3″ analogues (e.g., 12i) outperformed arterolane itself, producing cures in mice after a single oral exposure. Overall, this study suggests new avenues for modulating Fe(II) reactivity and the pharmacokinetic and pharmacodynamic properties of 1,2&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00699&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00699" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00699&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00699" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00699&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00699" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00699&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00699&amp;href=/doi/10.1021/acs.jmedchem.7b00699" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00699" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00699" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (642 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00699%26sid%3Dliteratum%253Aachs%26pmid%3D28692297%26genre%3Darticle%26aulast%3DBlank%26date%3D2017%26atitle%3DEnantioselective%2BSynthesis%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2BRegioisomeric%2BAnalogues%2Bof%2Bthe%2BAntimalarial%2BArterolane%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D14%26spage%3D6400%26epage%3D6407%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291452" title="Reactivity">Reactivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/jmcmar.2017.60.issue-14/20170727/jmcmar.2017.60.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of arterolane. Conformational analysis suggested that <i>trans</i>-3″-substituted trioxolanes would exhibit Fe(II) reactivity and antiparasitic activity similar to that achieved with canonical <i>cis</i>-4″ substitution. The chiral 3″ analogues were prepared as single stereoisomers and evaluated alongside their 4″ congeners against cultured malaria parasites and in a murine malaria model. As predicted, the <i>trans</i>-3″ analogues exhibited in vitro antiplasmodial activity remarkably similar to that of their <i>cis</i>-4″ comparators. In contrast, efficacy in the <i>Plasmodium berghei</i> mouse model differed dramatically for some of the congeneric pairs. The best of the novel 3″ analogues (e.g., <b>12i</b>) outperformed arterolane itself, producing cures in mice after a single oral exposure. Overall, this study suggests new avenues for modulating Fe(II) reactivity and the pharmacokinetic and pharmacodynamic properties of 1,2,4-trioxolane antimalarials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite recent progress in the control and treatment of malaria, this devastating disease still affects millions around the world and was estimated by the World Health Organization to have caused 429,000 deaths in 2015. The blood stage of infection is responsible for symptomatic disease, which is characterized by cyclical rounds of asexual replication of Plasmodium spp. parasites within host erythrocytes. To support its rapid proliferation in this stage of infection, the parasite depends on the catabolism of host hemoglobin as a source of amino acids. However, the consequent production of toxic free ferrous iron heme during this process represents an Achilles heel that is targeted in different ways by multiple classes of approved antimalarials, including quinolines and artemisinins.</div><div class="NLM_p">The sesquiterpene artemisinin (qinghaosu, <b>1</b>) and its analogues dihydroartemisinin (DHA) and artesunate are employed in artemisinin-based combination therapies (ACT), the current WHO recommended front line therapy for uncomplicated malaria caused by <i>Plasmodium falciparum</i>, the most virulent human malaria parasite. Artemisinins exhibit a novel pharmacology that requires initial activation of a hindered endoperoxide bond by reduced iron sources in the parasite. The iron-dependence and likely involvement of carbon-centered radical intermediates in artemisinin pharmacology were first revealed in the early 1990s in elegant mechanistic work involving synthetic artemisinin derivatives.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Soon, more synthetically accessible chemotypes were identified that, like the artemisinins, bore a peroxide bond in a sterically hindered environment. Most notably, Vennerstrom and co-workers identified the 1,2,4-trioxolane-based pharmacophore that produced both arterolane<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> (OZ277, <b>2a</b>) and artefenomel<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (OZ439, <b>3</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Clinical development of arterolane by Ranbaxy led to its approval in India and some African countries as a combination with piperaquine. Artefenomel was subsequently selected for clinical development on the basis of its much superior Fe(II) stability and in vivo PK/PD properties<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and is currently in Phase 2 clinical trials.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of antimalarial endoperoxides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent chemoproteomic studies<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> from two different groups have confirmed the long-hypothesized pleiotropic action of the artemisinins and demonstrated<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a remarkable concordance in the proteins covalently targeted by artemisinins and synthetic 1,2,4-trioxolanes. Hence, artemisinin and 1,2,4-trioxolane-derived affinity probes were shown to irreversibly label numerous proteins in the parasite, including those involved in energy acquisition, antioxidant response, and protein and DNA synthesis. Yet despite having many potential targets in the parasite, resistance to artemisinins has emerged in Southeast Asia and is now a significant clinical problem, especially with concomitant resistance to partner drugs.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The resistant phenotype results from mutations in the propeller domain of the PfKelch13 (K13) protein, which shares homology with the mammalian Keap1 protein.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These mutations appear to confer an enhanced stress response and a prolonged ring stage that allows K13 mutant parasites to better sustain the potent but short-lived insult conferred by artemisinins.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">A number of groups have now explored whether K13 mutations confer resistance also to antimalarial 1,2,4-trioxolanes, employing in vitro assays that focus on the kinetics of ring-stage killing. Thus, Tilley and co-workers<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> studied killing kinetics of DHA, <b>2a</b>, and <b>3</b> against a clinical K13 mutant strain and a genetically matched K13 revertant strain bearing the wild-type K13 allele. For all three agents, the time to reduce early ring viability by 50% (<i>t</i><sup>∧</sup><sub>50</sub>) was more than doubled in the K13 mutant strain compared to that in the revertant parasites. Thus, DHA and <b>2</b> exhibited <i>t</i><sup>∧</sup><sub>50</sub> values of ∼3 and ∼1 h for the K13 mutant and revertant strains, respectively, whereas <b>3</b> exhibited slower killing with <i>t</i><sup>∧</sup><sub>50</sub> values of ∼5 and ∼2 h. Using a ring-stage survival assay and a larger panel of K13 mutants, Fidock and co-workers<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> found that DHA and <b>2a</b> were uniformly less effective against the K13 strains when compared to revertant or wild-type controls. In contrast, compound <b>3</b> showed cross-resistance to only one of the K13 mutants examined (I543T). Finally, Wittlin and co-workers<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> studied clinical (<b>2a</b>, <b>3</b>) as well as additional preclinical trioxolane analogues against a K13 clinical isolate, finding that the synthetic trioxolanes were superior to DHA in a ring stage survival assay. Although the findings of these three studies are in some cases at odds, they are in general agreement that structurally distinct endoperoxide antimalarials can exhibit divergent effects on K13 mutant rings and that the superior in vivo exposure profile of <b>3</b> in humans predicts for efficacy in patients with K13 mutant parasites. Early data<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> from the clinical investigation of <b>3</b> suggests this is indeed the case.</div><div class="NLM_p last">The findings summarized above provide essential guidance for the optimization of endoperoxide antimalarials in the current environment of K13-mediated resistance. New agents should ideally confer rapid killing of wild-type and mutant K13 parasites while retaining a prolonged in vivo exposure profile that ideally enables single-dose therapy.<a onclick="showRef(event, 'ref9 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref13">(9, 13)</a> Among currently available agents, <b>3</b> meets this pharmacokinetic (PK) target, whereas <b>2a</b> and current artemisinins do not due to shorter durations of exposure in vivo. The identification of novel 1,2,4-trioxolanes that combine rapid ring-stage killing kinetics with superior pharmacokinetics will be expedited by new approaches for the control of endoperoxide reduction/activation by Fe(II). Here, we provide data suggesting that <i>trans</i>-3″-substitution of the cyclohexane ring, like canonical <i>cis</i>-4″ substitution, modulates Fe(II) reactivity of 1,2,4-trioxolanes in a pharmacologically relevant regime in vivo. Comparing congeneric sets of <i>trans</i>-3″ and <i>cis</i>-4″ analogues, we furthermore demonstrate that <i>trans</i>-3″ analogues can exhibit in vivo PK/PD properties distinct from <i>cis</i>-4″ comparators. Finally, we describe an efficient and stereocontrolled synthesis of <i>trans</i>-3<b>″-</b>substituted 1,2,4-trioxolane analogues that will enable further lead optimization studies of this chemotype.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis</h3><div class="NLM_p">The Fe(II) reactivity and resulting antimalarial effects of <b>2a</b> and <b>3</b> can be rationalized in terms of the conformational dynamics of the cyclohexane ring. In ground state conformer I (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), the axial endoperoxide lies in the concave face of an aliphatic surface with approach to the σ* orbital of the O–O bond effectively shielded by the four proximal axial hydrogen atoms of the adamantane and cyclohexane rings (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). It is the peroxide-equatorial conformer II that exposes the O–O bond for inner-sphere coordination with Fe(II) and single-electron transfer leading to bond scission.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Consistent with this interpretation is the highly regioselective nature of peroxide cleavage with reaction at the oxygen atom opposite the adamantane moiety predominating (O<sup>1</sup>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The crucial role of cyclohexane ring conformation on Fe(II) reactivity allows the latter to be finely tuned by varying the nature and stereochemistry of the 4″ substituent (i.e., R<sup>4</sup> in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The optimal balance of Fe(II) reactivity and antiplasmodial effects was ultimately achieved in analogues bearing <i>cis</i>-R<sup>4</sup> substitution that stabilizes unreactive conformer I. A focus on <i>cis</i>-R<sup>4</sup> substitution during lead optimization efforts ultimately produced both of the clinical candidates from this class (<b>2a</b> and <b>3</b>). Moreover, the improved stability of <b>3</b><sup>4</sup> as compared to <b>2a</b> toward endogenous Fe(II) sources can be understood as arising from more severe 1,3-diaxial interactions in conformer II of compound <b>3</b> due to the bulkier aryl R<sup>4</sup> side chain. Importantly, <b>3</b> still retains sufficient reactivity with free Fe(II) heme in parasites to confer a potent antimalarial effect.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Conformational Effects on Fe(II) Reactivity in Antimalarial 1,2,4-Trioxolanes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ability to predict Fe(II) reactivity on conformational grounds is very appealing from a design perspective and may prove essential in finding the right balance of in vivo stability toward endogenous Fe(II) sources (principally labile iron) and reactivity with Fe(II) heme necessary to target both susceptible and resistant parasites. We considered that <i>trans</i>-3″ substitution, nearly<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> unexplored previously, should modulate conformational dynamics in an analogous fashion as canonical <i>cis</i>-4″ substitution (R<sup>3</sup> vs R<sup>4</sup>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). In the case of <i>trans</i>-R<sup>3</sup> analogues, however, 1,3-diaxial interactions in conformer II would involve both O and H atoms as opposed to only H atoms in <i>cis</i>-R<sup>4</sup> analogues. Depending on the nature of the R<sup>3</sup>/R<sup>4</sup> side chain then, distinct conformational dynamics of the cyclohexane ring might be expected, and this would confer distinct in vitro and in vivo activities. Other important properties such as solubility, metabolism, and clearance were also expected to be affected by the switch to <i>trans</i>-R<sup>3</sup> substitution, which eliminates the internal symmetry present in <b>2a</b> and <b>3</b>, producing a distinct topology.</div><div class="NLM_p">The arterolane (<b>2a</b>) scaffold was selected for initial studies because a late-stage amide coupling reaction would allow ready access to the matched R<sup>3</sup>/R<sup>4</sup> analogue pairs. As comparators, we selected several R<sup>4</sup>-side chain derivatives described in patent applications<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and reported to possess reasonable in vivo efficacy with oral dosing. Thus, <b>2a</b> and nine additional R<sup>4</sup>-side chain analogues (<b>2b</b>–<b>j)</b> were synthesized<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> from acid intermediate <b>4</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and commercially available amines (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). We then turned our attention to construction of the analogous R<sup>3</sup>-side chain variants.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Arterolane and Related <i>cis</i>-4″ Analogues from Key Intermediate <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 75 min; R(R′)NH, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C to rt, 2–24 h, 71–95%. Reaction conditions adapted from ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>.</p></p></figure><div class="NLM_p">Unlike in analogues <b>2a</b>–<b>j</b>, which possess internal symmetry and are achiral, R<sup>3</sup> substitution leads to four possible stereoisomers. Because <i>trans</i>-R<sup>3</sup> stereochemistry was desired based on our conformational analysis, this left the <i>trans</i>-(<i>R,R</i>) and <i>trans</i>-(<i>S,S</i>) enantiomers as potential candidates for evaluation. We arbitrarily selected the <i>trans</i>-(<i>R,R</i>) stereoisomers for this initial study. Previously, we found<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> that the Griesbaum co-ozonolysis reaction of 3-substituted cyclohexanones proceeds with high (∼90:10 dr) intrinsic diastereoselectivity and favors the desired <i>trans</i> stereoisomer. Preparing the desired <i>trans</i>-(<i>R,R</i>) stereoisomer then required starting from an appropriate nonracemic 3-cyclohexanone. Toward this end, cyclohexanone <b>5</b> was prepared in 87% yield via catalytic asymmetric Michael addition of dimethyl malonate to 2-cyclohexen-1-one (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> Notably, this very practical synthesis of <b>5</b> has been performed previously on kilogram scales in a premanufacturing setting.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We confirmed the high enantiomeric purity of <b>5</b> (95% ee) by conversion to ketal <b>6</b>,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> the two diastereomers of which could be readily distinguished by <sup>13</sup>C NMR spectroscopy.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Enantiocontrolled Synthesis of Ketone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl malonate, (<i>R</i>)-ALB (1 mol %), <i>t</i>-BuOK (0.9 equiv relative to ALB), 4 Å MS, THF, rt, 68 h, 87%; (b) NaOH, H<sub>2</sub>O/THF (11:1), 0 °C, 2 h; (c) DMSO, 160 °C, 4 h, 85% over two steps.</p></p></figure><div class="NLM_p">A Krapcho decarboxylation was next considered as a means to produce the desired ester <b>7</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> from <b>5</b>. However, for the possibility of epimerization via retro-Michael/Michael addition of dimethyl malonate to be avoided, a two-step procedure was utilized instead.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thus, hydrolysis of <b>5</b> with NaOH at 0 °C afforded the mono-carboxylate intermediate, which was immediately heated to 160 °C to facilitate decarboxylation. This afforded <b>7</b> in 85% yield over two steps. Conversion of <b>7</b> to ketal <b>8</b> confirmed that the hydrolysis/decarboxylation sequence had proceeded without erosion of enantiomeric purity (94% ee for <b>7</b>). Griesbaum co-ozonolysis of <b>7</b> with two equivalents of oxime <b>9</b> at 0 °C using our optimized conditions<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> afforded 1,2,4-trioxolane intermediate <b>10</b> in nearly quantitative yield. Hydrolysis of ester <b>10</b> with NaOH then furnished the desired carboxylic acid <b>11</b> in excellent yield. From <b>11</b>, the desired 3″ amides <b>12a</b>–<b>k</b> were prepared in 68–95% yields via formation of the mixed anhydride (ethyl chloroformate and Et<sub>3</sub>N at −10 °C) and subsequent reaction with primary or secondary amines (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). We were able to confirm that the Griesbaum co-ozonolysis of <b>7</b> and <b>9</b> had proceeded with good diastereoselectivity (91:9 dr) by the preparation of analogue <b>12k</b> in which trans and cis diastereomers could be readily distinguished by NMR.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Stereocontrolled Synthesis of 1,2,4-Trioxolane Analogues <b>12a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 0.5 equiv of <b>7</b>, O<sub>3</sub>, CCl<sub>4</sub>, 0 °C, 3 h, 95%; (b) NaOH, EtOH/H<sub>2</sub>O, 50 °C, 4 h, 95%; (c) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 75 min; R(R′)NH, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C to rt, 2–24 h, 68–95%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Evaluation of Congener Pairs</h3><div class="NLM_p">The effect of R<sup>3</sup> substitution on antiplasmodial activity was evaluated by comparing the regioisomeric analogues <b>2a</b>–<b>j</b> and <b>12a</b>–<b>j</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). New <i>trans</i>-R<sup>3</sup> analogues exhibited potent, low nM activities against the chloroquine-resistant W2 strain of <i>P. falciparum</i> with activity comparable to that of <i>cis</i>-R<sup>4</sup> comparators. Moreover, structure–activity trends tracked remarkably closely in the regioisomeric scaffolds consistent with our hypothesis that <i>trans</i>-R<sup>3</sup> substitution should confer similar conformational constraints and Fe(II) reactivity as <i>cis</i>-R<sup>4</sup> substitution. In both scaffolds, piperidine amides (<b>12e</b> and <b>2e)</b> were the least potent, approximately 10- to 20-fold weaker than piperazine analogues <b>12g</b> and <b>2g</b>. The most significant difference between regioisomer pairs was observed for morpholine amides <b>12f</b> and <b>2f</b>, where 3″ analogue <b>12f</b> was 3-fold more potent than that of <b>2f</b>. Overall, these findings confirmed that <i>trans</i>-R<sup>3</sup> substitution modulates 1,2,4-trioxolane reactivity in a pharmacologically relevant range, producing effects on cultured parasites that are comparable to those of canonical <i>cis</i>-R<sup>4</sup> substitution.</div><figure id="cht1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. In Vitro Activity of Trioxolanes <b>12a</b>–<b>j</b> and <b>2a</b>–<b>j</b> against W2 <i>P. falciparum</i> Parasites<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>In vitro activity of <b>12a</b>–<b>j</b> and <b>2a</b>–<b>j</b> against W2 <i>P. falciparum</i> parasites (EC<sub>50</sub> ± SEM). Reported EC<sub>50</sub> values are the means of three determinations ± SEM</p></p></figure><div class="NLM_p">A second hypothesis regarding <i>trans</i>-R<sup>3</sup> substitution was that the resulting desymmetrized molecular topology would impact the in vivo PK/PD properties of these analogues. Specifically, we reasoned that the chiral <i>trans</i>-R<sup>3</sup> analogues might interact differently with CYP enzymes and drug transporters (e.g., P-gp). To explore possible metabolic differences, we evaluated selected analogues with mouse liver microsomes and derived intrinsic clearance (CL<sub>int</sub>) values (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). All the analogues evaluated exhibited low or moderate CL<sub>int</sub> values that would predict reasonable exposure in vivo. In four of the six analogue pairs evaluated, it was the <i>trans</i>-R<sup>3</sup> analogues that exhibited higher CL<sub>int</sub> values with <i>trans</i>-R<sup>3</sup> analogues <b>12a</b> and <b>12c</b> showing lower intrinsic clearance than their <i>cis</i>-R<sup>4</sup> comparators. Clearance appeared to be CYP mediated in all cases, with the possible exception of <b>2c</b>, where chemical instability or non-CYP-mediated clearance was implicated. The kinetic solubilities of arterolane (<b>2a</b>) and its regioisomer <b>12a</b> were evaluated and found to be comparable. Overall, the in vitro ADME data suggested that <i>trans</i>-R<sup>3</sup> analogues were suitable for evaluation in animals and that specific analogues might be differentiated from their comparators in vivo.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro ADME Data for Selected Trioxolane Analogues and Controls</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char="." /></col><col align="char" char=" " /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=" "><i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=" "><i>T</i><sub>1/2</sub> (min) no NADPH</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char=" ">128</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char=".">433</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=" ">169</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char=".">429</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=" ">124</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=" ">37.3</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=" ">64.2</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td><td class="colsep0 rowsep0" align="char" char=" ">70</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=" ">84.5</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=" ">136</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="char" char=" ">161</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="char" char=" ">64.2</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="char" char=" ">48.1</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td><td class="colsep0 rowsep0" align="char" char=" ">88.9</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="char" char=" ">25.5</td><td class="colsep0 rowsep0" align="char" char=".">27.2</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="char" char=" ">277</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="char" char=" ">84.5</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=" ">stable</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">midazolam</td><td class="colsep0 rowsep0" align="char" char=" ">1.65</td><td class="colsep0 rowsep0" align="char" char=".">420</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diclofenac</td><td class="colsep0 rowsep0" align="char" char=" ">55.5</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amiodarone</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char="."><3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testosterone</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=".">315</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Half-life when incubated with mouse liver microsomes.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Clearance in units of μL min<sup>–1</sup> mg<sup>–1</sup> of protein calculated as CL<sub>int</sub> = ln(2)*1000/<i>T</i><sub>1/2</sub>/protein concentration, where protein concentration is in mg/mL; midazolam and diclofenac served as controls.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Kinetic solubility in PBS (pH 7.4) at a final DMSO concentraion of 5% as an average of three determinations; amiodarone and testosterone served as controls.</p></div></div></div><div class="NLM_p">The suppressive 4-day “Peters test”<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> involving <i>P. berghei</i> infected mice provides a convenient and cost-effective means to assess the overall in vivo performance of preclinical antimalarials. Thus, groups of five <i>P. berghei</i> infected female Swiss Webster mice were treated via oral gavage with four daily (QD) doses of either <b>2a</b> (as the tosylate salt), regioisomeric comparator <b>12a</b> (both tosylate and free base), or chloroquine control (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Mice were followed for 30 days and judged to have been cured of the infection based on the lack of detectable parasitemia at the end of the study. In this initial study, <i>trans</i>-R<sup>3</sup> analogue <b>12a</b> as either tosylate salt or free base exhibited efficacy comparable to arterolane tosylate, producing cures in all five animals.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Efficacy of Trioxolanes <b>12a</b> and <b>2a</b> and Controls in <i>P. berghei</i>-Infected Mice Treated for 4 Days<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">salt form</th><th class="colsep0 rowsep0" align="center" char=" ">dose (mg kg<sup>–1</sup> day<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">tosylate</td><td class="colsep0 rowsep0" align="char" char=" ">13.6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">tosylate</td><td class="colsep0 rowsep0" align="char" char=" ">13.6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">free base</td><td class="colsep0 rowsep0" align="char" char=" ">9.5</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">30</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle treated</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">untreated</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i>-infected female Swiss Webster mice were treated once a day for 4 days by oral gavage.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div><div class="NLM_p">This result indicated that <b>12a</b> was orally absorbed and achieved systemic exposure sufficient to produce a robust pharmacodynamic response. Prior to evaluating additional <i>trans</i>-R<sup>3</sup> analogues, we sought to determine the 50% curative dose for both <b>12a</b> and <b>2a</b> in this model and use this dose as a benchmark for future studies. Thus, compounds <b>12a</b> and <b>2a</b> (both as free bases) were administered to mice over 4 days at doses of 10, 6, 4, or 1 mg kg<sup>–1</sup> day<sup>–1</sup>, and survival and parasitemia were monitored until 30 days postinfection. This study revealed a clear dose–efficacy relationship and allowed us to estimate 50% curative dose (PD<sub>50</sub>) values of ∼6 mg kg<sup>–1</sup> day<sup>–1</sup> for <b>12a</b> and ∼4 mg kg<sup>–1</sup> day<sup>–1</sup> for <b>2a</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). With the <i>trans</i>-R<sup>3</sup> chemotype validated in vivo and a relatively stringent dose/efficacy benchmark established, we set out to more broadly evaluate the matched pairs of regioisomeric analogues in animals.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vivo Efficacy of <b>12a</b> and <b>2a</b> in <i>P. berghei</i>-Infected Mice Following Four Daily Doses<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center" char=" ">dose<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (mg kg<sup>–1</sup> day<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">10</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">10</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">untreated</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i>-infected female Swiss Webster mice were treated once a day for 4 days by oral gavage at the indicated daily dose.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div><div class="NLM_p">As noted previously, the <i>cis</i>-R<sup>4</sup> amide comparators were selected in part based on in vivo efficacy data in patents and other reports<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> from the Vennerstrom group. Therefore, all nine <i>cis</i>-R<sup>4</sup> analogues were expected to have good in vivo prospects, whereas the in vivo performance of the <i>trans</i>-R<sup>3</sup> comparators was less certain. In the next study then, all 20 test compounds (<b>2a</b>–<b>j</b> and <b>12a</b>–<b>j</b>) were evaluated under 4 and 6 mg/kg daily dosing protocols in groups of five Swiss Webster mice. Controls <b>12a</b> and <b>2a</b> again showed good efficacy at these low doses with analogue <b>12a</b> marginally more effective than <b>2a</b> in this study (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Among the other nine analogue pairs, four pairs failed to cure any mice at either dosing level. These analogues included the glycinamide (<b>12b</b> and <b>2b</b>), piperidine (<b>12e</b> and <b>2e</b>), morpholine (<b>12f</b> and <b>2f</b>), and <i>N</i>-methyl piperazine (<b>12h</b> and <b>2h</b>) analogues. Interestingly, whereas the piperidine and piperazine analogues failed in these studies, the structurally very similar 4-aminopiperidine derivatives <b>2i</b> and <b>12i</b> were among the most efficacious analogues examined, curing all animals at the lowest dose of 4 mg kg<sup>–1</sup> day<sup>–1</sup> and proving superior to <b>12a</b> and <b>2a</b>. This finding regarding <b>2i</b> is consistent with a previous report<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> demonstrating the superiority of <b>2i</b> over <b>2a</b> in a similar murine model with 3 days oral dosing at 3 mg/kg. Thus, for many of the analogue pairs, in vivo efficacy seemed to track between the <i>cis</i>-R<sup>4</sup> and <i>trans</i>-R<sup>3</sup> comparators.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo Efficacy of Matched Analogue Pairs in <i>P. berghei</i>-Infected Mice<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=" ">dose (mg kg<sup>–1</sup> day<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2j</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">6</td><td class="colsep0 rowsep0" align="char" char=" ">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="char" char=" ">30</td><td class="colsep0 rowsep0" align="char" char=" ">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="char" char=" "> </td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i>-infected female Swiss Webster mice were treated once a day for 4 days by oral gavage.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div><div class="NLM_p">Of greatest interest were those analogue pairs for which in vivo efficacy varied between the <i>trans</i>-R<sup>3</sup> and <i>cis</i>-R<sup>4</sup> comparators. Most strikingly, <i>cis</i>-R<sup>4</sup> analogues <b>2d</b> and <b>2g</b> were fully effective at 6 mg kg<sup>–1</sup> day<sup>–1</sup>, whereas the analogous <i>trans</i>-R<sup>3</sup> comparators <b>12d</b> and <b>12g</b> failed entirely or were minimally effective (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In the case of the analogue pair <b>12c</b> and <b>2c</b>, however, it was the novel <i>trans</i>-R<sup>3</sup> analogue <b>12c</b> that produced full cure at either dose, whereas the <i>cis</i>-R<sup>4</sup> derivative <b>2c</b> was essentially ineffective. Thus, regioisomeric trioxolane analogues can in some cases exhibit starkly different efficacy in vivo despite having similar intrinsic potency against cultured parasites. These results confirmed our hopes that <i>trans</i>-R<sup>3</sup> substitution might offer new avenues for the optimization of PK/PD properties in preclinical 1,2,4-trioxolanes. In the case of analogue pairs <b>12c</b> and <b>2c</b>, <b>12d</b> and <b>2d</b>, and <b>12g</b> and <b>2g</b>, CL<sub>int</sub> values from the mouse liver microsome assay correctly predicted the superior analogue in each pair (compare <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). However, the magnitude of differences in CL<sub>int</sub> values seems insufficient to fully explain the differences observed, nor do the CL<sub>int</sub> values alone explain the failure of <b>12b</b> and <b>2b</b>. It appears that additional in vivo PK/PD studies will be required to fully understand the relative merits of 3″ and 4″ substitution within the context of specific side chain types.</div><div class="NLM_p">Given that the novel <i>trans</i>-R<sup>3</sup> analogues <b>12c</b> and <b>12i</b> demonstrated complete cures at 4 mg kg<sup>–1</sup> day<sup>–1</sup>, we next explored whether even lower doses of these agents might be effective in mice. Although <b>12c</b> and <b>12i</b> again cured all animals at a 4 mg kg<sup>–1</sup> day<sup>–1</sup> dose, neither produced cures with reduced doses of 2, 1, or 0.5 mg kg<sup>–1</sup> day<sup>–1</sup> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). We next asked whether a full 4 days of treatment at 4 mg kg<sup>–1</sup> day<sup>–1</sup> was necessary to achieve cures with <b>12c</b> and <b>12i</b>, cognizant that current antimalarial target product profiles seek agents with shortened dosing regimens. When <b>12c</b> and <b>12i</b> were administered at 4 mg/kg for 4, 3, 2, or 1 day, a predictable decline in efficacy with the number of doses was observed (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Thus, both compounds were again fully effective at four daily doses of 4 mg/kg, and <b>12i</b> was shown to be superior to <b>12c</b> with three daily doses of 4 mg/kg (60 vs 20% of animals cured for <b>12i</b> and <b>12c</b>, respectively). Neither compound was curative with one or two daily doses of 4 mg/kg, although under these regimens mouse survival was extended ∼3–6 days compared to that of vehicle-treated control animals.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Efficacy of <b>12c</b> and <b>12i</b> in <i>P. berghei</i>-Infected Mice at Various Dosing Levels<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=" ">dose (mg kg<sup>–1</sup> day<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=" ">0.5</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="char" char=" ">0.5</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i>-infected female Swiss Webster mice were treated once a day for 4 days by oral gavage.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo Efficacy of <b>12c</b> and <b>12i</b> in <i>P. berghei</i>-Infected Mice with Less Frequent Dosing<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=" ">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=" ">number of doses</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">3</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">3</td><td class="colsep0 rowsep0" align="char" char=" ">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">4</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i> infected female Swiss Webster mice were treated once a day by oral gavage for either four, three, two, or 1 day as shown above.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div><div class="NLM_p">In a final in vivo study, we evaluated the efficacy of <b>12c</b> and <b>12i</b> following a single dose of 40 or 80 mg/kg or two doses of 40 mg/kg (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). We included as a positive control in this study artefenomel (<b>3</b>),<a onclick="showRef(event, 'ref4 ref29'); return false;" href="javascript:void(0);" class="ref ref4 ref29">(4, 29)</a> which is known to be highly effective in these models. Indeed, a single dose of <b>3</b> was remarkably effective, curing all animals at both doses examined. Although the new analogues <b>12c</b> and <b>12i</b> were completely effective with two doses of 40 mg kg<sup>–1</sup> day<sup>–1</sup>, a single dose of 40 mg/kg was only partially effective for <b>12i</b> and ineffective for <b>12c</b>. Both compounds were partially effective with a single 80 mg/kg dose and again <b>12i</b> proved superior to <b>12c</b> (60 vs 20% cures). Thus, multiple PD studies consistently revealed analogue <b>12i</b> to be the most promising of the novel <i>trans</i>-3″ analogues explored herein, although it was inferior to artefenomel (<b>3</b>), which has demonstrated<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> single-dose cures at 20 mg/kg in similar models.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Efficacy of <b>12c</b>, <b>12i</b>, and Artefenomel in <i>P. berghei</i>-Infected Mice Following a Single or Repeated Dose<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=" ">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=" ">number of doses</th><th class="colsep0 rowsep0" align="center" char=" ">mice cured<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (artefenomel)</td><td class="colsep0 rowsep0" align="char" char=" ">40</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">80</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=" ">40</td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">40</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">80</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="char" char=" ">40</td><td class="colsep0 rowsep0" align="char" char=" ">2</td><td class="colsep0 rowsep0" align="char" char=" ">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">40</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" ">80</td><td class="colsep0 rowsep0" align="char" char=" ">1</td><td class="colsep0 rowsep0" align="char" char=" ">60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Beginning 1 h after infection, cohorts of five <i>P. berghei</i>-infected female Swiss Webster mice were treated by oral gavage for either 1 or 2 days at the indicated dose.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Mice were considered cured if there was no detectable parasitemia at 30 days postinfection.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The unusual Fe(II)-dependent pharmacology of antimalarial 1,2,4-trioxolanes necessitates an equally unusual approach to their optimization, namely, one that recognizes and exploits the strong connection between conformational dynamics, chemical reactivity, and antiparasitic effects.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Clinical experience with <b>2a</b> and <b>3</b> perfectly illustrates this point. Thus, early clinical studies of <b>2a</b> revealed inferior drug exposure and half-life in malaria patients when compared to healthy volunteers. This effect was traced to reaction of <b>2a</b> with endogenous Fe(II) sources in infected individuals. Nevertheless, by modifying the nature of the <i>cis</i>-4″ side chain, a superior drug candidate (<b>3</b>) with much improved Fe(II) stability and in vivo PK properties was identified.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Now, an improved understanding<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> of how emergent K13 mutant parasites escape endoperoxide exposure provides rationale for identifying new endoperoxides that more rapidly kill <i>P. falciparum</i> K13 mutant ring forms while retaining stability toward endogenous Fe(II) sources in the host. The result of just such an effort focused on a tetraoxane chemotype has appeared very recently.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(30)</a></div><div class="NLM_p last">Here, we present the first systematic study comparing the canonical <i>cis</i>-4″-substituted pharmacophore of <b>2a</b> and <b>3</b> with regioisomeric <i>trans</i>-3″-substituted analogues. On the basis of their in vitro and in vivo properties, we conclude that the <i>trans</i>-3″ side chain modulates peroxide reactivity in a pharmacologically relevant regime as hoped. In this preliminary study, we examined just ten side chains employed previously in <i>cis</i>-4″ analogues. Even with this limited survey, two novel analogues were identified that exhibited in vivo properties superior to <b>2a</b> in the <i>P. berghei</i> model, and one that afforded single-dose cures at higher doses. The ultimate potential of the new 3″-substituted chemotype will only be revealed with the examination of a more diverse set of side chains, and in particular, those designed to exploit steric and conformational effects unique to this substitution pattern. Efforts in this direction are well underway in our laboratories and will be described in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Known compounds were prepared according to literature procedures as cited in the main text. The syntheses of new compounds <b>12a</b>–<b>k</b> are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_001.pdf" class="ext-link">Supporting Information</a>. All compounds tested in parasites or mice were judged to be of >95% purity as assessed using a Waters Micromass ZQ 4000 equipped with Waters 2795 Separation Module, Waters 2996 Photodiode Array Detector (254 nm), and Waters 2424 ELS detector. Separations were carried out with an XBridge BEH C18, 3.5 μm, 4.6 × 20 mm column, at ambient temperature (unregulated) using a mobile phase of water–methanol containing a constant 0.10% formic acid.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>Plasmodium falciparum</i> EC<sub>50</sub> Determinations</h3><div class="NLM_p last">The growth inhibition assay for <i>P. falciparum</i> was conducted as described previously<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(31)</a> with minor modifications. Briefly, <i>Plasmodium falciparum</i> strain W2 synchronized ring-stage parasites were cultured in human red blood cells in 96-well flat bottom culture plates at 37 °C, adjusted to 1% parasitemia and 2% hematocrit under an atmosphere of 3% O<sub>2</sub>, 5% CO<sub>2</sub>, and 91% N<sub>2</sub> in a final volume of 0.1 mL per well in RPMI-1640 media supplemented with 0.5% Albumax, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 100 mM hypoxanthine in the presence of various concentrations of inhibitors. Tested compounds were serially diluted 1:3 in the range 10000–4.6 nM (or 1000–0.006 nM for more potent analogues) with a maximum DMSO concentration of 0.1%. Following 48 h of incubation, the cells were fixed by adding 0.1 mL of 2% formaldehyde in phosphate buffered saline, pH 7.4 (PBS). Parasite growth was evaluated by flow cytometry on a FACsort (Becton Dickinson) equipped with AMS-1 loader (Cytek Development) after staining with 1 nM of the DNA dye YOYO-1 (Molecular Probes) in 100 mM NH<sub>4</sub>Cl and 0.1% Triton x-100 in 0.8% NaCl. Parasitemias were determined from dot plots (forward scatter vs fluorescence) using CELLQUEST software (Becton Dickinson). EC<sub>50</sub> values for growth inhibition were determined from plots of percentage control parasitemia over inhibitor concentration using GraphPad Prism software.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>Plasmodium berghei</i> Mouse Malaria Model</h3><div class="NLM_p last">Female Swiss Webster Mice (average of 20 g body weight) were infected intraperitoneally with 10<sup>6</sup><i>Plasmodium berghei</i>-infected erythrocytes collected from a previously infected mouse. Beginning 1 h after inoculation, the mice were treated once daily by oral gavage for 1–4 days with 100 μL of solution of test compound formulated in a vehicle comprised of 10% DMSO, 40% of a 20% solution of 2-hydroxypropyl-β-cyclodextrin in water, and 50% PEG400. There were five mice in each test arm. Infections were monitored by daily microscopic evaluation of Giemsa-stained blood smears starting on day 7. Parasitemia were determined by counting the number of infected and uninfected erythrocytes. Body weight was measured over the course of the treatment. Mice were euthanized when parasitemia exceeded 50% or when weight loss of more than 15% occurred. Animal survival and morbidity were closely monitored for up to 30 days postinfection when the experiment was terminated.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00699">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00699" class="ext-link">10.1021/acs.jmedchem.7b00699</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedures and compound characterization for new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_001.pdf">jm7b00699_si_001.pdf (293.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_002.csv">jm7b00699_si_002.csv (7.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00699" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam R. Renslo</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmaceutical Chemistry and ‡Department of Medicine, University of California San Francisco, 1700 Fourth Street, San
Francisco, California 94158, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link">http://orcid.org/0000-0002-1240-2846</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afcecbcec281ddcac1dcc3c0efdaccdcc981cacbda"><span class="__cf_email__" data-cfemail="49282d2824673b2c273a2526093c2a3a2f672c2d3c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian R. Blank</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmaceutical Chemistry and ‡Department of Medicine, University of California San Francisco, 1700 Fourth Street, San
Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiri Gut</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmaceutical Chemistry and ‡Department of Medicine, University of California San Francisco, 1700 Fourth Street, San
Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip J. Rosenthal</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmaceutical Chemistry and ‡Department of Medicine, University of California San Francisco, 1700 Fourth Street, San
Francisco, California 94158, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>B.R.B., J.G., and A.R.R conceived experiments. B.R.B. devised synthetic routes and synthesized compounds. B.R.B. and J.G. acquired data. All authors analyzed data. A.R.R. supervised the project. B.R.B. and A.R.R wrote the manuscript. All authors reviewed, edited, and commented on the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3158-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">A.R.R. acknowledges funding from the US National Institutes of Health (R01 Grant AI105106). We thank Prof. J. Vennerstrom for the generous gift of intermediate <b>4</b>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> Abbreviations Used</h2><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">dihydroartemisinin</p></td></tr><tr><td class="NLM_term">ACT</td><td class="NLM_def"><p class="first last">artemisinins combination therapy</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome assay</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once-daily dosing</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Posner, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C. H.</span><span> </span><span class="NLM_article-title">A Regiospecifically Oxygen-18 Labeled 1, 2, 4-Trioxane: A Simple Chemical Model System To Probe the Mechanism(s) for the Antimalarial Activity of Artemisinin (Qinghaosu)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">8328</span><span class="NLM_x">–</span> <span class="NLM_lpage">8329</span><span class="refDoi"> DOI: 10.1021/ja00047a076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00047a076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=8328-8329&author=G.+H.+Posnerauthor=C.+H.+Oh&title=A+Regiospecifically+Oxygen-18+Labeled+1%2C+2%2C+4-Trioxane%3A+A+Simple+Chemical+Model+System+To+Probe+the+Mechanism%28s%29+for+the+Antimalarial+Activity+of+Artemisinin+%28Qinghaosu%29&doi=10.1021%2Fja00047a076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fja00047a076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00047a076%26sid%3Dliteratum%253Aachs%26aulast%3DPosner%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DC.%2BH.%26atitle%3DA%2520Regiospecifically%2520Oxygen-18%2520Labeled%25201%252C%25202%252C%25204-Trioxane%253A%2520A%2520Simple%2520Chemical%2520Model%2520System%2520To%2520Probe%2520the%2520Mechanism%2528s%2529%2520for%2520the%2520Antimalarial%2520Activity%2520of%2520Artemisinin%2520%2528Qinghaosu%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D8328%26epage%3D8329%26doi%3D10.1021%2Fja00047a076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Posner, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhous, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshnick, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asawamahasadka, W.</span><span> </span><span class="NLM_article-title">Mechanism-Based Design, Synthesis and in Vitro Antimalarial Testing of New 4-Methylated Trioxanes Structurally Related to Artemisinin: The Importance of a Carbon-Centered Radical for Antimalarial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1021/jm00035a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00035a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1256-1258&author=G.+H.+Posnerauthor=C.+H.+Ohauthor=D.+Wangauthor=L.+Gerenaauthor=W.+K.+Milhousauthor=S.+R.+Meshnickauthor=W.+Asawamahasadka&title=Mechanism-Based+Design%2C+Synthesis+and+in+Vitro+Antimalarial+Testing+of+New+4-Methylated+Trioxanes+Structurally+Related+to+Artemisinin%3A+The+Importance+of+a+Carbon-Centered+Radical+for+Antimalarial+Activity&doi=10.1021%2Fjm00035a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00035a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00035a003%26sid%3Dliteratum%253Aachs%26aulast%3DPosner%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DMilhous%26aufirst%3DW.%2BK.%26aulast%3DMeshnick%26aufirst%3DS.%2BR.%26aulast%3DAsawamahasadka%26aufirst%3DW.%26atitle%3DMechanism-Based%2520Design%252C%2520Synthesis%2520and%2520in%2520Vitro%2520Antimalarial%2520Testing%2520of%2520New%25204-Methylated%2520Trioxanes%2520Structurally%2520Related%2520to%2520Artemisinin%253A%2520The%2520Importance%2520of%2520a%2520Carbon-Centered%2520Radical%2520for%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1256%26epage%3D1258%26doi%3D10.1021%2Fjm00035a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorneaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Identification of an Antimalarial Synthetic Trioxolane Drug Development Candidate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/nature02779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fnature02779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=15318224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=900-904&author=J.+L.+Vennerstromauthor=S.+Arbe-Barnesauthor=R.+Brunauthor=S.+A.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=Y.+Dongauthor=A.+Dornauthor=D.+Hunzikerauthor=H.+Matileauthor=K.+McIntoshauthor=M.+Padmanilayamauthor=J.+Santo+Tomasauthor=C.+Scheurerauthor=B.+Scorneauxauthor=Y.+Tangauthor=H.+Urwylerauthor=S.+Wittlinauthor=W.+N.+Charman&title=Identification+of+an+Antimalarial+Synthetic+Trioxolane+Drug+Development+Candidate&doi=10.1038%2Fnature02779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an antimalarial synthetic trioxolane drug development candidate</span></div><div class="casAuthors">Vennerstrom, Jonathan L.; Arbe-Barnes, Sarah; Brun, Reto; Charman, Susan A.; Chiu, Francis C. K.; Chollet, Jacques; Dong, Yuxiang; Dorn, Arnulf; Hunziker, Daniel; Matile, Hugues; McIntosh, Kylie; Padmanilayam, Maniyan; Santo Tomas, Josefina; Scheurer, Christian; Scorneaux, Bernard; Tang, Yuanqing; Urwyler, Heinrich; Wittlin, Sergio; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7002</span>),
    <span class="NLM_cas:pages">900-904</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of artemisinin more than 30 yr ago provided a completely new antimalarial structural prototype; i.e., a mol. with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle.  Available evidence suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by hem, released as a result of Hb digestion by the malaria-causing parasite.  This irreversible redox reaction produces carbon-centered free radicals, leading to alkylation of hem and proteins (enzymes), one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be crit. to parasite survival.  Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs.  The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indexes and provide for successful treatment outcomes.  However, as a drug class, the artemisinins suffer from chem. (semi-synthetic availability, purity and cost), biopharmaceutical (poor bioavailability and limiting pharmacokinetics) and treatment (noncompliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential.  Here the authors describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwBOuKiqjSbVg90H21EOLACvtfcHk0liUWAKoKxjNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D&md5=71070255d32c12fe3c227d5091225b31</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature02779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02779%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DHunziker%26aufirst%3DD.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DIdentification%2520of%2520an%2520Antimalarial%2520Synthetic%2520Trioxolane%2520Drug%2520Development%2520Candidate%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D900%26epage%3D904%26doi%3D10.1038%2Fnature02779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papastogiannidis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingelin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Synthetic Ozonide Drug Candidate OZ439 Offers New Hope for a Single-Dose Cure of Uncomplicated Malaria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span><span class="refDoi"> DOI: 10.1073/pnas.1015762108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.1015762108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=21300861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=4400-4405&author=S.+A.+Charmanauthor=S.+Arbe-Barnesauthor=I.+C.+Bathurstauthor=R.+Brunauthor=M.+Campbellauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=J.+C.+Craftauthor=D.+J.+Creekauthor=Y.+Dongauthor=H.+Matileauthor=M.+Maurerauthor=J.+Morizziauthor=T.+Nguyenauthor=P.+Papastogiannidisauthor=C.+Scheurerauthor=D.+M.+Shacklefordauthor=K.+Sriraghavanauthor=L.+Stingelinauthor=Y.+Tangauthor=H.+Urwylerauthor=X.+Wangauthor=K.+L.+Whiteauthor=S.+Wittlinauthor=L.+Zhouauthor=J.+L.+Vennerstrom&title=Synthetic+Ozonide+Drug+Candidate+OZ439+Offers+New+Hope+for+a+Single-Dose+Cure+of+Uncomplicated+Malaria&doi=10.1073%2Fpnas.1015762108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span></div><div class="casAuthors">Charman, Susan A.; Arbe-Barnes, Sarah; Bathurst, Ian C.; Brun, Reto; Campbell, Michael; Charman, William N.; Chiu, Francis C. K.; Chollet, Jacques; Craft, J. Carl; Creek, Darren J.; Dong, Yuxiang; Matile, Hugues; Maurer, Melanie; Morizzi, Julia; Nguyen, Tien; Papastogiannidis, Petros; Scheurer, Christian; Shackleford, David M.; Sriraghavan, Kamaraj; Stingelin, Lukas; Tang, Yuanqing; Urwyler, Heinrich; Wang, Xiaofang; White, Karen L.; Wittlin, Sergio; Zhou, Lin; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4400-4405, S4400/1-S4400/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ozonide OZ439 is a synthetic peroxide antimalarial drug candidate designed to provide a single-dose oral cure in humans.  OZ439 has successfully completed Phase I clin. trials, where it was shown to be safe at doses up to 1,600 mg and is currently undergoing Phase Ila trials in malaria patients.  Herein, we describe the discovery of OZ439 and the exceptional antimalarial and pharmacokinetic properties that led to its selection as a clin. drug development candidate.  In vitro, OZ439 is fast-acting against all asexual erythrocytic Plasmodium falciparum stages with ICs0 values comparable to those for the clin. used artemisinin derivs.  Unlike all other synthetic peroxides and semisynthetic artemisinin derivs., OZ439 completely cures Plasmodium berghei-infected mice with a single oral dose of 20 mg/kg and exhibits prophylactic activity superior to that of the benchmark chemoprophylactic agent, mefloquine.  Compared with other peroxide-contg. antimalarial agents, such as the artemisinin derivs. and the first-generation ozonide OZ277, OZ439 exhibits a substantial increase in the pharmacokinetic half-life and blood concn. vs. time profile in three preclin. species.  The outstanding efficacy and prolonged blood concns. of OZ439 are the result of a design strategy that stabilizes the intrinsically unstable pharmacophoric peroxide bond, thereby reducing clearance yet maintaining the necessary Fe(II)-reactivity to elicit parasite death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxoUteI8z2bVg90H21EOLACvtfcHk0liUWAKoKxjNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D&md5=5da13be1d57a8dd58b21246814f6c268</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015762108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015762108%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBathurst%26aufirst%3DI.%2BC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DStingelin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSynthetic%2520Ozonide%2520Drug%2520Candidate%2520OZ439%2520Offers%2520New%2520Hope%2520for%2520a%2520Single-Dose%2520Cure%2520of%2520Uncomplicated%2520Malaria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D4400%26epage%3D4405%26doi%3D10.1073%2Fpnas.1015762108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Moehrle, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duparc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siethoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Giersbergen, P. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">First-in-Man Safety and Pharmacokinetics of Synthetic Ozonide OZ439 Demonstrates an Improved Exposure Profile Relative to Other Peroxide Antimalarials</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04368.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1111%2Fj.1365-2125.2012.04368.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=22759078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1KksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=524-537&author=J.+J.+Moehrleauthor=S.+Duparcauthor=C.+Siethoffauthor=P.+L.+M.+van+Giersbergenauthor=J.+C.+Craftauthor=S.+Arbe-Barnesauthor=S.+A.+Charmanauthor=M.+Gutierrezauthor=S.+Wittlinauthor=J.+L.+Vennerstrom&title=First-in-Man+Safety+and+Pharmacokinetics+of+Synthetic+Ozonide+OZ439+Demonstrates+an+Improved+Exposure+Profile+Relative+to+Other+Peroxide+Antimalarials&doi=10.1111%2Fj.1365-2125.2012.04368.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials</span></div><div class="casAuthors">Moehrle, Joerg J.; Duparc, Stephan; Siethoff, Christoph; van Giersbergen, Paul L. M.; Craft, J. Carl; Arbe-Barnes, Sarah; Charman, Susan A.; Gutierrez, Maria; Wittlin, Sergio; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-537</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess the safety and pharmacokinetics of a new synthetic ozonide antimalarial, OZ439, in a first-in-man, double-blind study in healthy volunteers.  OZ439 was administered as single oral daily doses of a capsule formulation (50-1200 mg) or an oral dispersion (400-1600 mg, fed and fasted states) and for up to 3 days as an oral dispersion (200-800 mg day-1).  Plasma concns. of OZ439 and its metabolites were measured by LC-MS.  The pharmacokinetic (PK) profile of OZ439 was characterized by a tmax of around 3 h, followed by a multiphasic profile with a terminal half-life of 25-30 h.  The PK parameters were approx. dose proportional for each group and profiles of the metabolites followed a similar pattern to that of the parent compd.  Following dosing for 3 days, accumulation was less than two-fold but steady-state was not achieved.  In the presence of food, no effect was obsd. on the t1/2 of OZ439 while the exposure was increased by 3 to 4.5-fold.  Exposure was higher and inter-subject variability was reduced when OZ439 was administered as an oral dispersion compared with a capsule.  The urinary clearance of OZ439 and its metabolites was found to be negligible and OZ439 did not induce CYP3A4.  The antimalarial activity profiles of a subset of serum samples suggested that the major antimalarial activity originated from OZ439 rather than from any of the metabolites.  The safety and pharmacokinetic profile of OZ439 merits progression to phase 2a proof of concept studies in the target population of acute uncomplicated malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz6xjkmmkaUbVg90H21EOLACvtfcHk0ljavJfnMMnRdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1KksA%253D%253D&md5=703c3e1cd02a888e2e282ae1b7fbaf8a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04368.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04368.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DSiethoff%26aufirst%3DC.%26aulast%3Dvan%2BGiersbergen%26aufirst%3DP.%2BL.%2BM.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DFirst-in-Man%2520Safety%2520and%2520Pharmacokinetics%2520of%2520Synthetic%2520Ozonide%2520OZ439%2520Demonstrates%2520an%2520Improved%2520Exposure%2520Profile%2520Relative%2520to%2520Other%2520Peroxide%2520Antimalarials%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D524%26epage%3D537%26doi%3D10.1111%2Fj.1365-2125.2012.04368.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Phyo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jittamala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pukrittayakamee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imwong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duparc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möhrle, J. J.</span><span> </span><span class="NLM_article-title">Antimalarial Activity of Artefenomel (OZ439), a Novel Synthetic Antimalarial Endoperoxide, in Patients with Plasmodium Falciparum and Plasmodium Vivax Malaria: An Open-Label Phase 2 Trial</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)00320-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS1473-3099%2815%2900320-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26448141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wjs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=61-69&author=A.+P.+Phyoauthor=P.+Jittamalaauthor=F.+H.+Nostenauthor=S.+Pukrittayakameeauthor=M.+Imwongauthor=N.+J.+Whiteauthor=S.+Duparcauthor=F.+Macintyreauthor=M.+Bakerauthor=J.+J.+M%C3%B6hrle&title=Antimalarial+Activity+of+Artefenomel+%28OZ439%29%2C+a+Novel+Synthetic+Antimalarial+Endoperoxide%2C+in+Patients+with+Plasmodium+Falciparum+and+Plasmodium+Vivax+Malaria%3A+An+Open-Label+Phase+2+Trial&doi=10.1016%2FS1473-3099%2815%2900320-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial</span></div><div class="casAuthors">Phyo, Aung Pyae; Jittamala, Podjanee; Nosten, Francois H.; Pukrittayakamee, Sasithon; Imwong, Mallika; White, Nicholas J.; Duparc, Stephan; MacIntyre, Fiona; Baker, Mark; Mohrle, Jorg J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artefenomel (OZ439) is a novel synthetic trioxolane with improved pharmacokinetic properties compared with other antimalarial drugs with the artemisinin pharmacophore.  Artefenomel has been generally well tolerated in volunteers at doses up to 1600 mg and is being developed as a partner drug in an antimalarial combination treatment.  We investigated the efficacy, tolerability, and pharmacokinetics of artefenomel at different doses in patients with Plasmodium falciparum or Plasmodium vivax malaria.  This phase 2a exploratory, open-label trial was done at the Hospital for Tropical Diseases, Bangkok, and the Shoklo Malaria Research Unit in Thailand.  Adult patients with acute, uncomplicated P falciparum or P vivax malaria received artefenomel in a single oral dose (200 mg, 400 mg, 800 mg, or 1200 mg).  The first cohort received 800 mg.  Testing of a new dose of artefenomel in a patient cohort was decided on after safety and efficacy assessment of the preceding cohort.  The primary endpoint was the natural log parasite redn. per 24 h.  Definitive oral treatment was given at 36 h.  This trial is registered with ClinicalTrials.gov, no. NCT01213966.  Between Oct 24, 2010, and May 25, 2012, 82 patients were enrolled (20 in each of the 200 mg, 400 mg, and 800 mg cohorts, and 21 in the 1200 mg cohort).  One patient withdrew consent (before the administration of artefenomel) but there were no further dropouts.  The parasite redn. rates per 24 h ranged from 0·90 to 1·88 for P falciparum, and 2·09 to 2·53 for P vivax.  All doses were equally effective in both P falciparum and P vivax malaria, with median parasite clearance half-lives of 4·1 h (range 1·3-6·7) to 5·6 h (2·0-8·5) for P falciparum and 2·3 h (1·2-3·9) to 3·2 h (0·9-15·0) for P vivax.  Maximum plasma concns., dose-proportional to 800 mg, occurred at 4 h (median).  The estd. elimination half-life was 46-62 h.  No serious drug-related adverse effects were reported; other adverse effects were generally mild and reversible, with the highest no. in the 1200 mg cohort (17 [81%] patients with at least one adverse event).  The most frequently reported adverse effect was an asymptomatic increase in plasma creatine phosphokinase concn. (200 mg, n=5; 400 mg, n=3; 800 mg, n=1; 1200 mg, n=3).  Artefenomel is a new synthetic antimalarial peroxide with a good safety profile that clears parasitemia rapidly in both P falciparum and P vivax malaria.  Its long half-life suggests a possible use in a single-dose treatment in combination with other drugs.  Bill & Melinda Gates Foundation, Wellcome Trust, and UK Department for International Development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_OEYJuv5VVrVg90H21EOLACvtfcHk0ljavJfnMMnRdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wjs7vP&md5=368550e5ec73242c603c8abdc6a66f12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900320-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900320-5%26sid%3Dliteratum%253Aachs%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DNosten%26aufirst%3DF.%2BH.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26atitle%3DAntimalarial%2520Activity%2520of%2520Artefenomel%2520%2528OZ439%2529%252C%2520a%2520Novel%2520Synthetic%2520Antimalarial%2520Endoperoxide%252C%2520in%2520Patients%2520with%2520Plasmodium%2520Falciparum%2520and%2520Plasmodium%2520Vivax%2520Malaria%253A%2520An%2520Open-Label%2520Phase%25202%2520Trial%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D61%26epage%3D69%26doi%3D10.1016%2FS1473-3099%2815%2900320-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ismail, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charoensutthivarakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span> </span><span class="NLM_article-title">A Click Chemistry-Based Proteomic Approach Reveals That 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">6511</span><span class="NLM_x">–</span> <span class="NLM_lpage">6515</span><span class="refDoi"> DOI: 10.1002/ange.201512062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fange.201512062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=6511-6515&author=H.+M.+Ismailauthor=V.+E.+Bartonauthor=M.+Panchanaauthor=S.+Charoensutthivarakulauthor=G.+A.+Biaginiauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=A+Click+Chemistry-Based+Proteomic+Approach+Reveals+That+1%2C2%2C4-Trioxolane+and+Artemisinin+Antimalarials+Share+a+Common+Protein+Alkylation+Profile&doi=10.1002%2Fange.201512062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fange.201512062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.201512062%26sid%3Dliteratum%253Aachs%26aulast%3DIsmail%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DV.%2BE.%26aulast%3DPanchana%26aufirst%3DM.%26aulast%3DCharoensutthivarakul%26aufirst%3DS.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DA%2520Click%2520Chemistry-Based%2520Proteomic%2520Approach%2520Reveals%2520That%25201%252C2%252C4-Trioxolane%2520and%2520Artemisinin%2520Antimalarials%2520Share%2520a%2520Common%2520Protein%2520Alkylation%2520Profile%26jtitle%3DAngew.%2520Chem.%26date%3D2016%26volume%3D128%26spage%3D6511%26epage%3D6515%26doi%3D10.1002%2Fange.201512062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ismail, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phanchana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charoensutthivarakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemingway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span> </span><span class="NLM_article-title">Artemisinin Activity-Based Probes Identify Multiple Molecular Targets within the Asexual Stage of the Malaria Parasites Plasmodium Falciparum 3D7</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2080</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span><span class="refDoi"> DOI: 10.1073/pnas.1600459113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.1600459113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26858419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit12ktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=2080-2085&author=H.+M.+Ismailauthor=V.+Bartonauthor=M.+Phanchanaauthor=S.+Charoensutthivarakulauthor=M.+H.+L.+Wongauthor=J.+Hemingwayauthor=G.+A.+Biaginiauthor=P.+M.+O%E2%80%99Neillauthor=S.+A.+Ward&title=Artemisinin+Activity-Based+Probes+Identify+Multiple+Molecular+Targets+within+the+Asexual+Stage+of+the+Malaria+Parasites+Plasmodium+Falciparum+3D7&doi=10.1073%2Fpnas.1600459113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7</span></div><div class="casAuthors">Ismail, Hanafy M.; Barton, Victoria; Phanchana, Matthew; Charoensutthivarakul, Sitthivut; Wong, Michael H. L.; Hemingway, Janet; Biagini, Giancarlo A.; O'Neill, Paul M.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2080-2085</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The artemisinin (ART)-based antimalarials have contributed significantly to reducing global malaria deaths over the past decade, but the authors still do not know how they kill parasites.  To gain greater insight into the potential mechanisms of ART drug action, the authors developed a suite of ART activity-based protein profiling probes to identify parasite protein drug targets in situ.  Probes were designed to retain biol. activity and alkylate the mol. target(s) of Plasmodium falciparum 3D7 parasites in situ.  Proteins tagged with the ART probe can then be isolated using click chem. before identification by liq. chromatog.-MS/MS.  Using these probes, the authors define an ART proteome that shows alkylated targets in the glycolytic, Hb degrdn., antioxidant defense, and protein synthesis pathways, processes essential for parasite survival.  This work reveals the pleiotropic nature of the biol. functions targeted by this important class of antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe38he4JorxrVg90H21EOLACvtfcHk0limsXrNXDTKSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit12ktb8%253D&md5=50a46614e45c5e2e7c819675679ec4a1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1600459113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1600459113%26sid%3Dliteratum%253Aachs%26aulast%3DIsmail%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DV.%26aulast%3DPhanchana%26aufirst%3DM.%26aulast%3DCharoensutthivarakul%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%2BH.%2BL.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DArtemisinin%2520Activity-Based%2520Probes%2520Identify%2520Multiple%2520Molecular%2520Targets%2520within%2520the%2520Asexual%2520Stage%2520of%2520the%2520Malaria%2520Parasites%2520Plasmodium%2520Falciparum%25203D7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D2080%26epage%3D2085%26doi%3D10.1073%2Fpnas.1600459113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, C. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span> </span><span class="NLM_article-title">Haem-Activated Promiscuous Targeting of Artemisinin in Plasmodium Falciparum</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">10111</span><span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.-J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Y.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.-X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.-C.+Huaauthor=B.+Liuauthor=H.-M.+Shenauthor=K.+S.+W.+Tanauthor=Q.+Lin&title=Haem-Activated+Promiscuous+Targeting+of+Artemisinin+in+Plasmodium+Falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0limsXrNXDTKSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.-J.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%2BY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.-X.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.-C.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.-M.%26aulast%3DTan%26aufirst%3DK.%2BS.%2BW.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-Activated%2520Promiscuous%2520Targeting%2520of%2520Artemisinin%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Try, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessborn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullo, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarning, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span> </span><span class="NLM_article-title">Dihydroartemisinin–Piperaquine Resistance in Plasmodium Falciparum Malaria in Cambodia: A Multisite Prospective Cohort Study</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)00487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS1473-3099%2815%2900487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26774243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=357-365&author=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=C.+Sophaauthor=B.+Samauthor=D.+Dekauthor=V.+Tryauthor=R.+Amatoauthor=D.+Blessbornauthor=L.+Songauthor=G.+S.+Tulloauthor=M.+P.+Fayauthor=J.+M.+Andersonauthor=J.+Tarningauthor=R.+M.+Fairhurst&title=Dihydroartemisinin%E2%80%93Piperaquine+Resistance+in+Plasmodium+Falciparum+Malaria+in+Cambodia%3A+A+Multisite+Prospective+Cohort+Study&doi=10.1016%2FS1473-3099%2815%2900487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span></div><div class="casAuthors">Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Sopha, Chantha; Sam, Baramey; Dek, Dalin; Try, Vorleak; Amato, Roberto; Blessborn, Daniel; Song, Lijiang; Tullo, Gregory S.; Fay, Michael P.; Anderson, Jennifer M.; Tarning, Joel; Fairhurst, Rick M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria.  Recent treatment failures with dihydroartemisinin-piperaquine, the current first-line ACT in Cambodia, suggest that piperaquine resistance may be emerging in this country.  We explored the relation between artemisinin resistance and dihydroartemisinin-piperaquine failures, and sought to confirm the presence of piperaquine-resistant P falciparum infections in Cambodia.  In this prospective cohort study, we enrolled patients aged 2-65 years with uncomplicated P falciparum malaria in three Cambodian provinces: Pursat, Preah Vihear, and Ratanakiri.  Participants were given std. 3-day courses of dihydroartemisinin-piperaquine.  Peripheral blood parasite densities were measured until parasites cleared and then weekly to 63 days.  The primary outcome was recrudescent P falciparum parasitemia within 63 days.  We measured piperaquine plasma concns. at baseline, 7 days, and day of recrudescence.  We assessed phenotypic and genotypic markers of drug resistance in parasite isolates.  The study is registered with ClinicalTrials.gov, no. NCT01736319.  Between Sept 4, 2012, and Dec 31, 2013, we enrolled 241 participants.  In Pursat, where artemisinin resistance is entrenched, 37 (46%) of 81 patients had parasite recrudescence.  In Preah Vihear, where artemisinin resistance is emerging, ten (16%) of 63 patients had recrudescence and in Ratanakiri, where artemisinin resistance is rare, one (2%) of 60 patients did.  Patients with recrudescent P falciparum infections were more likely to have detectable piperaquine plasma concns. at baseline compared with non-recrudescent patients, but did not differ significantly in age, initial parasite d., or piperaquine plasma concns. at 7 days.  Recrudescent parasites had a higher prevalence of kelch13 mutations, higher piperaquine 50% inhibitory concn. (IC50) values, and lower mefloquine IC50 values; none had multiple pfmdr1 copies, a genetic marker of mefloquine resistance.  Dihydroartemisinin-piperaquine failures are caused by both artemisinin and piperaquine resistance, and commonly occur in places where dihydroartemisinin-piperaquine has been used in the private sector.  In Cambodia, artesunate plus mefloquine may be a viable option to treat dihydroartemisinin-piperaquine failures, and a more effective first-line ACT in areas where dihydroartemisinin-piperaquine failures are common.  The use of single low-dose primaquine to eliminate circulating gametocytes is needed in areas where artemisinin and ACT resistance is prevalent.  National Institute of Allergy and Infectious Diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0RSM1qQzR7Vg90H21EOLACvtfcHk0limsXrNXDTKSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D&md5=b2b62ae0ef4f2b67f7446a2a5718654d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900487-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DDek%26aufirst%3DD.%26aulast%3DTry%26aufirst%3DV.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DBlessborn%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTullo%26aufirst%3DG.%2BS.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26atitle%3DDihydroartemisinin%25E2%2580%2593Piperaquine%2520Resistance%2520in%2520Plasmodium%2520Falciparum%2520Malaria%2520in%2520Cambodia%253A%2520A%2520Multisite%2520Prospective%2520Cohort%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D357%26epage%3D365%26doi%3D10.1016%2FS1473-3099%2815%2900487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, D.</span><span> </span><span class="NLM_article-title">A Molecular Marker of Artemisinin-Resistant Plasmodium Falciparum Malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+Molecular+Marker+of+Artemisinin-Resistant+Plasmodium+Falciparum+Malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eY2Dorw_1aI3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520Molecular%2520Marker%2520of%2520Artemisinin-Resistant%2520Plasmodium%2520Falciparum%2520Malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Dogovski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chotivanich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozdech, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klonis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, L.</span><span> </span><span class="NLM_article-title">Targeting the Cell Stress Response of Plasmodium Falciparum to Overcome Artemisinin Resistance</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002132</span><span class="refDoi"> DOI: 10.1371/journal.pbio.1002132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1371%2Fjournal.pbio.1002132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=25901609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=e1002132&author=C.+Dogovskiauthor=S.+C.+Xieauthor=G.+Burgioauthor=J.+Bridgfordauthor=S.+Mokauthor=J.+M.+McCawauthor=K.+Chotivanichauthor=S.+Kennyauthor=N.+Gn%C3%A4digauthor=J.+Straimerauthor=Z.+Bozdechauthor=D.+A.+Fidockauthor=J.+A.+Simpsonauthor=A.+M.+Dondorpauthor=S.+Footeauthor=N.+Klonisauthor=L.+Tilley&title=Targeting+the+Cell+Stress+Response+of+Plasmodium+Falciparum+to+Overcome+Artemisinin+Resistance&doi=10.1371%2Fjournal.pbio.1002132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance</span></div><div class="casAuthors">Dogovski, Con; Xie, Stanley C.; Burgio, Gaetan; Bridgford, Jess; Mok, Sachel; McCaw, James M.; Chotivanich, Kesinee; Kenny, Shannon; Gnadig, Nina; Straimer, Judith; Bozdech, Zbynek; Fidock, David A.; Simpson, Julie A.; Dondorp, Arjen M.; Foote, Simon; Klonis, Nectarios; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1002132/1-e1002132/26</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Successful control of falciparum malaria depends greatly on treatment with artemisinin combination therapies.  Thus, reports that resistance to artemisinins (ARTs) has emerged, and that the prevalence of this resistance is increasing, are alarming.  ART resistance has recently been linked to mutations in the K13 propeller protein.  The authors undertook a detailed kinetic anal. of the drug responses of K13 wild-type and mutant isolates of Plasmodium falciparum sourced from a region in Cambodia (Pailin).  They demonstrate that ART treatment induces growth retardation and an accumulation of ubiquitinated proteins, indicative of a cellular stress response that engages the ubiquitin/proteasome system.  They show that resistant parasites exhibit lower levels of ubiquitinated proteins and delayed onset of cell death, indicating an enhanced cell stress response.  The stress response could be targeted by inhibiting the proteasome.  Accordingly, clin. used proteasome inhibitors strongly synergize ART activity against both sensitive and resistant parasites, including isogenic lines expressing mutant or wild-type K13.  Synergy is also obsd. against Plasmodium berghei in vivo.  The authors developed a detailed model of parasite responses that enabled them to infer in vivo parasite clearance profiles from in vitro assessments of ART sensitivity.  They provide evidence that the clin. marker of resistance (delayed parasite clearance) is an indirect measure of drug efficacy because of the persistence of unviable parasites with unchanged morphol. in the circulation, and we suggest alternative approaches for the direct measurement of viability.  This model predicts that extending current three-day ART treatment courses to four days, or splitting the doses, will efficiently clear resistant parasite infections.  This work provides a rationale for improving the detection of ART resistance in the field and for treatment strategies that can be employed in areas with ART resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnq1k3owGeKbVg90H21EOLACvtfcHk0lg9m1zRAtAs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVGqu7c%253D&md5=acb11e532b67d900a54958ceebee8db1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002132%26sid%3Dliteratum%253Aachs%26aulast%3DDogovski%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DBurgio%26aufirst%3DG.%26aulast%3DBridgford%26aufirst%3DJ.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DMcCaw%26aufirst%3DJ.%2BM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DKenny%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DJ.%2BA.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DFoote%26aufirst%3DS.%26aulast%3DKlonis%26aufirst%3DN.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520Cell%2520Stress%2520Response%2520of%2520Plasmodium%2520Falciparum%2520to%2520Overcome%2520Artemisinin%2520Resistance%26jtitle%3DPLoS%2520Biol.%26date%3D2015%26volume%3D13%26spage%3De1002132%26doi%3D10.1371%2Fjournal.pbio.1002132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannangelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klonis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, L.</span><span> </span><span class="NLM_article-title">Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium Falciparum Strains</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4501</span><span class="NLM_x">–</span> <span class="NLM_lpage">4510</span><span class="refDoi"> DOI: 10.1128/AAC.00574-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1128%2FAAC.00574-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=27161632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSis7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=4501-4510&author=T.+Yangauthor=S.+C.+Xieauthor=P.+Caoauthor=C.+Giannangeloauthor=J.+McCawauthor=D.+J.+Creekauthor=S.+A.+Charmanauthor=N.+Klonisauthor=L.+Tilley&title=Comparison+of+the+Exposure+Time+Dependence+of+the+Activities+of+Synthetic+Ozonide+Antimalarials+and+Dihydroartemisinin+against+K13+Wild-Type+and+Mutant+Plasmodium+Falciparum+Strains&doi=10.1128%2FAAC.00574-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the exposure time dependence of the activities of synthetic ozonide antimalarials and dihydroartemisinin against K13 wild-type and mutant Plasmodium falciparum strains</span></div><div class="casAuthors">Yang, Tuo; Xie, Stanley C.; Cao, Pengxing; Giannangelo, Carlo; McCaw, James; Creek, Darren J.; Charman, Susan A.; Klonis, Nectarios; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4501-4510</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Fully synthetic endoperoxide antimalarials, namely, OZ277 (RBx11160; also known as arterolane) and OZ439 (artefenomel), have been approved for marketing or are currently in clin. development.  We undertook an anal. of the kinetics of the in vitro responses of Plasmodium falciparum to the new ozonide antimalarials.  For these studies we used a K13 mutant (artemisinin resistant) isolate from a region in Cambodia and a genetically matched (artemisinin sensitive) K13 revertant.  We used a pulsed-exposure assay format to interrogate the time dependence of the response.  Because the ozonides have physicochem. properties different from those of the artemisinins, assay optimization was required to ensure that the drugs were completely removed following the pulsed exposure.  Like that of artemisinins, ozonide activity requires active Hb degrdn.  Short pulses of the ozonides were less effective than short pulses of dihydroartemisinin; however, when early-ring-stage parasites were exposed to drugs for periods relevant to their in vivo exposure, the ozonide antimalarials were markedly more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdXqYkFnGmlbVg90H21EOLACvtfcHk0liAR3Dy9YbZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSis7zP&md5=390e3f479b4a3a953d550293ec91fcaf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.00574-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00574-16%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DGiannangelo%26aufirst%3DC.%26aulast%3DMcCaw%26aufirst%3DJ.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKlonis%26aufirst%3DN.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DComparison%2520of%2520the%2520Exposure%2520Time%2520Dependence%2520of%2520the%2520Activities%2520of%2520Synthetic%2520Ozonide%2520Antimalarials%2520and%2520Dihydroartemisinin%2520against%2520K13%2520Wild-Type%2520and%2520Mutant%2520Plasmodium%2520Falciparum%2520Strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D4501%26epage%3D4510%26doi%3D10.1128%2FAAC.00574-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00172</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1128/mBio.00172-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1128%2FmBio.00172-17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e00172-17&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+H.+Stokesauthor=M.+Ehrenbergerauthor=A.+A.+Craneauthor=D.+A.+Fidock&title=Plasmodium+falciparum+K13+Mutations+Differentially+Impact+Ozonide+Susceptibility+and+Parasite+Fitness&doi=10.1128%2FmBio.00172-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.00172-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00172-17%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3DEhrenberger%26aufirst%3DM.%26aulast%3DCrane%26aufirst%3DA.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPlasmodium%2520falciparum%2520K13%2520Mutations%2520Differentially%2520Impact%2520Ozonide%2520Susceptibility%2520and%2520Parasite%2520Fitness%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26spage%3De00172%26epage%3D17%26doi%3D10.1128%2FmBio.00172-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Baumgärtner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span> </span><span class="NLM_article-title">In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="refDoi"> DOI: 10.1186/s12936-017-1696-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1186%2Fs12936-017-1696-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=28122617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A280%3ADC%252BC1c7pt1Gnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=45&author=F.+Baumg%C3%A4rtnerauthor=J.+Jourdanauthor=C.+Scheurerauthor=B.+Blascoauthor=B.+Campoauthor=P.+M%C3%A4serauthor=S.+Wittlin&title=In+vitro+activity+of+anti-malarial+ozonides+against+an+artemisinin-resistant+isolate&doi=10.1186%2Fs12936-017-1696-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate</span></div><div class="casAuthors">Baumgartner Fabian; Jourdan Joelle; Scheurer Christian; Maser Pascal; Wittlin Sergio; Baumgartner Fabian; Jourdan Joelle; Scheurer Christian; Maser Pascal; Wittlin Sergio; Blasco Benjamin; Campo Brice</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recently published data suggest that artemisinin derivatives and synthetic peroxides, such as the ozonides OZ277 and OZ439, have a similar mode of action.  Here the cross-resistance of OZ277 and OZ439 and four additional next-generation ozonides was probed against the artemisinin-resistant clinical isolate Plasmodium falciparum Cam3.I, which carries the K13-propeller mutation R539T (Cam3.I(R539T)).  METHODS:  The previously described in vitro ring-stage survival assay (RSA0-3h) was employed and a simplified variation of the original protocol was developed.  RESULTS:  At the pharmacologically relevant concentration of 700 nM, all six ozonides were highly effective against the dihydroartemisinin-resistant P. falciparum Cam3.I(R539T) parasites, showing a per cent survival ranging from <0.01 to 1.83%.  A simplified version of the original RSA0-3h method was developed and gave similar results, thus providing a practical drug discovery tool for further optimization of next-generation anti-malarial peroxides.  CONCLUSION:  The absence of in vitro cross-resistance against the artemisinin-resistant clinical isolate Cam3.I(R539T) suggests that ozonides could be effective against artemisinin-resistant P. falciparum.  How this will translate to the human situation in clinical settings remains to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT81D1FD4aMH-kdrW1FkXG-fW6udTcc2ebvfrsL7gaKb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7pt1Gnsg%253D%253D&md5=3ef0b5011d7a16980762522cd3f65926</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-1696-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-1696-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumg%25C3%25A4rtner%26aufirst%3DF.%26aulast%3DJourdan%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520activity%2520of%2520anti-malarial%2520ozonides%2520against%2520an%2520artemisinin-resistant%2520isolate%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D45%26doi%3D10.1186%2Fs12936-017-1696-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Creek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCullough, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Iron-Mediated Degradation Kinetics of Substituted Dispiro-1,2,4-Trioxolane Antimalarials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">2956</span><span class="refDoi"> DOI: 10.1002/jps.20958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fjps.20958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=17549767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2945-2956&author=D.+Creekauthor=W.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=K.+J.+McCulloughauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Iron-Mediated+Degradation+Kinetics+of+Substituted+Dispiro-1%2C2%2C4-Trioxolane+Antimalarials&doi=10.1002%2Fjps.20958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials</span></div><div class="casAuthors">Creek, Darren J.; Charman, William N.; Chiu, Francis C. K.; Prankerd, Richard J.; McCullough, Kevin J.; Dong, Yuxiang; Vennerstrom, Jonathan L.; Charman, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2945-2956</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The iron-mediated reactivity of various dispiro-1,2,4-trioxolanes was detd. by automated kinetic anal. under std. reaction conditions.  The active antimalarial compds. underwent peroxide bond cleavage by Fe(II) resulting in products indicative of carbon-centered radical formation.  The rate of reaction was heavily influenced by the presence of spiro-substituted adamantane and cyclohexane rings, and was also significantly affected by cyclohexane ring substitution.  Steric hindrance around the peroxide oxygen atoms appeared to be the major determinant of reaction rate, however polar substituents also affected reactivity by an independent mechanism.  A wide range of reaction rates was obsd. within this class of peroxide antimalarials, however iron-mediated reactivity did not directly correlate with in vitro antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbEl3gTAvtQbVg90H21EOLACvtfcHk0liAR3Dy9YbZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzL&md5=7381da53247f1de3a3cf78b4b152694e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjps.20958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20958%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DMcCullough%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DIron-Mediated%2520Degradation%2520Kinetics%2520of%2520Substituted%2520Dispiro-1%252C2%252C4-Trioxolane%2520Antimalarials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2945%26epage%3D2956%26doi%3D10.1002%2Fjps.20958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship of an Ozonide Carboxylic Acid (OZ78) Against Fasciola Hepatica</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4223</span><span class="NLM_x">–</span> <span class="NLM_lpage">4233</span><span class="refDoi"> DOI: 10.1021/jm100226t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100226t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4223-4233&author=Q.+Zhaoauthor=M.+Vargasauthor=Y.+Dongauthor=L.+Zhouauthor=X.+Wangauthor=K.+Sriraghavanauthor=J.+Keiserauthor=J.+L.+Vennerstrom&title=Structure-Activity+Relationship+of+an+Ozonide+Carboxylic+Acid+%28OZ78%29+Against+Fasciola+Hepatica&doi=10.1021%2Fjm100226t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of an Ozonide Carboxylic Acid (OZ78) against Fasciola hepatica</span></div><div class="casAuthors">Zhao, Qingjie; Vargas, Mireille; Dong, Yuxiang; Zhou, Lin; Wang, Xiaofang; Sriraghavan, Kamaraj; Keiser, Jennifer; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4223-4233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we describe the SAR of ozonide carboxylic acid OZ78 (1) as the first part of our search for a trematocidal synthetic peroxide drug development candidate.  We found that relatively small structural changes to 1 resulted most commonly in loss of activity against Fasciola hepatica in vivo.  A spiroadamantane substructure and acidic functional group (or ester prodrug) were required for activity.  Of 26 new compds. administered at single 100 mg/kg oral doses to F. hepatica infected rats, 8 had statistically significant worm burden redns., 7 were partially curative, and 1 (acylsulfonamide 6) was completely curative and comparable to 1 in flukicidal efficacy.  This study also showed that the activity of 1 is peroxide-bond-dependent, suggesting that its flukicidal efficacy depends upon Hb digestion in F. hepatica.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1lLdePK_TXrVg90H21EOLACvtfcHk0lil6V9SuQPXKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWju74%253D&md5=e525e022c0adc026c10c5b69b6d3f8de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm100226t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100226t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DVargas%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520an%2520Ozonide%2520Carboxylic%2520Acid%2520%2528OZ78%2529%2520Against%2520Fasciola%2520Hepatica%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4223%26epage%3D4233%26doi%3D10.1021%2Fjm100226t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Vennerstrom, J. L.; Dong, Y.; Chollet, J.; Matile, H.; Padmanilayam, M.; Tang, Y.; Charman, W. N.</span><span> </span><span class="NLM_article-title">Spiro and Dispiro 1,2,4-trioxolane Antimalarials</span>. U.S. Patent 2004/0039008 A1, February 26,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+L.+Vennerstrom&author=Y.+Dong&author=J.+Chollet&author=H.+Matile&author=M.+Padmanilayam&author=Y.+Tang&author=W.+N.+Charman&title=Spiro+and+Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSpiro%2520and%2520Dispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yadav, G. C.; Dorwal, H. N.; Valavala, S.; Sharma, V. K.</span><span> </span><span class="NLM_article-title">A Process for the Preparation of Spiro and Dispiro 1,2,4-trioxolane Antimalarials</span>. PCT WO 2007/138435 A2, December 6,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+C.+Yadav&author=H.+N.+Dorwal&author=S.+Valavala&author=V.+K.+Sharma&title=A+Process+for+the+Preparation+of+Spiro+and+Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DG.%2BC.%26atitle%3DA%2520Process%2520for%2520the%2520Preparation%2520of%2520Spiro%2520and%2520Dispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5776</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span><span class="refDoi"> DOI: 10.1021/ol5028392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5028392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5776-5779&author=S.+D.+Fontaineauthor=A.+G.+Dipasqualeauthor=A.+R.+Renslo&title=Efficient+and+Stereocontrolled+Synthesis+of+1%2C2%2C4-Trioxolanes+Useful+for+Ferrous+Iron-Dependent+Drug+Delivery&doi=10.1021%2Fol5028392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span></div><div class="casAuthors">Fontaine, Shaun D.; DiPasquale, Antonio G.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5776-5779</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferrous iron-promoted redn. of a hindered peroxide bond underlies the antimalarial action of the 1,2,4-trioxane artemisinin and the 1,2,4-trioxolane arterolane.  In appropriately designed systems, a 1,2,4-trioxolane ring can serve as a trigger to realize ferrous iron-dependent and parasite-selective drug delivery, both in vitro and in vivo.  A stereocontrolled, expeditious (three steps), and efficient (67-71% overall yield) synthesis of 1,2,4-trioxolanes, e.g., I possessing the requisite 3'' substitution pattern that enables ferrous iron-dependent drug delivery is reported.  The key synthetic step involves a diastereoselective Griesbaum co-ozonolysis reaction to afford primarily products with a trans relationship between the 3'' substituent and the peroxide bridge, as confirmed by X-ray structural anal. of a 3''-substituted 4-nitrobenzoate analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRW_OGGkPS7Vg90H21EOLACvtfcHk0lil6V9SuQPXKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE&md5=960d52771a3c0b91d4fc3b07c2d4a0ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol5028392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5028392%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DDipasquale%26aufirst%3DA.%2BG.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DEfficient%2520and%2520Stereocontrolled%2520Synthesis%2520of%25201%252C2%252C4-Trioxolanes%2520Useful%2520for%2520Ferrous%2520Iron-Dependent%2520Drug%2520Delivery%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5776%26epage%3D5779%26doi%3D10.1021%2Fol5028392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shibasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span> </span><span class="NLM_article-title">Asymmetric Catalysis with Heterobimetallic Compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1002/anie.199712361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fanie.199712361" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=1236-1256&author=M.+Shibasakiauthor=H.+Sasaiauthor=T.+Arai&title=Asymmetric+Catalysis+with+Heterobimetallic+Compounds&doi=10.1002%2Fanie.199712361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.199712361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199712361%26sid%3Dliteratum%253Aachs%26aulast%3DShibasaki%26aufirst%3DM.%26aulast%3DSasai%26aufirst%3DH.%26aulast%3DArai%26aufirst%3DT.%26atitle%3DAsymmetric%2520Catalysis%2520with%2520Heterobimetallic%2520Compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1997%26volume%3D36%26spage%3D1236%26epage%3D1256%26doi%3D10.1002%2Fanie.199712361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M.</span><span> </span><span class="NLM_article-title">A Catalytic Asymmetric Synthesis of Tubifolidine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7547</span><span class="NLM_x">–</span> <span class="NLM_lpage">7551</span><span class="refDoi"> DOI: 10.1021/jo981069g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo981069g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7547-7551&author=S.+Shimizuauthor=K.+Ohoriauthor=T.+Araiauthor=H.+Sasaiauthor=M.+Shibasaki&title=A+Catalytic+Asymmetric+Synthesis+of+Tubifolidine&doi=10.1021%2Fjo981069g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo981069g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981069g%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DOhori%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DSasai%26aufirst%3DH.%26aulast%3DShibasaki%26aufirst%3DM.%26atitle%3DA%2520Catalytic%2520Asymmetric%2520Synthesis%2520of%2520Tubifolidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7547%26epage%3D7551%26doi%3D10.1021%2Fjo981069g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M. A.</span><span> </span><span class="NLM_article-title">A Practical Large-Scale Synthesis of Enantiomerically Pure 3-[Bis(methoxycarbonyl)methyl]cyclohexanone via Catalytic Asymmetric Michael Reaction</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1016/S0040-4020(02)00141-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS0040-4020%2802%2900141-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2585-2588&author=Y.+Xuauthor=K.+Ohoriauthor=T.+Ohshimaauthor=M.+A.+Shibasaki&title=A+Practical+Large-Scale+Synthesis+of+Enantiomerically+Pure+3-%5BBis%28methoxycarbonyl%29methyl%5Dcyclohexanone+via+Catalytic+Asymmetric+Michael+Reaction&doi=10.1016%2FS0040-4020%2802%2900141-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900141-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900141-2%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DOhori%26aufirst%3DK.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DM.%2BA.%26atitle%3DA%2520Practical%2520Large-Scale%2520Synthesis%2520of%2520Enantiomerically%2520Pure%25203-%255BBis%2528methoxycarbonyl%2529methyl%255Dcyclohexanone%2520via%2520Catalytic%2520Asymmetric%2520Michael%2520Reaction%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2585%26epage%3D2588%26doi%3D10.1016%2FS0040-4020%2802%2900141-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tzvetkov, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmoldt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattay, J.</span><span> </span><span class="NLM_article-title">Synthesis of Optically Active (1R,4S,6S)-6-hydroxybicyclo[2.2.2]octan-2-One</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1016/j.tetasy.2006.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2Fj.tetasy.2006.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=993-998&author=N.+T.+Tzvetkovauthor=P.+Schmoldtauthor=B.+Neumannauthor=H.-G.+Stammlerauthor=J.+Mattay&title=Synthesis+of+Optically+Active+%281R%2C4S%2C6S%29-6-hydroxybicyclo%5B2.2.2%5Doctan-2-One&doi=10.1016%2Fj.tetasy.2006.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2006.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2006.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DSchmoldt%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DB.%26aulast%3DStammler%26aufirst%3DH.-G.%26aulast%3DMattay%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Optically%2520Active%2520%25281R%252C4S%252C6S%2529-6-hydroxybicyclo%255B2.2.2%255Doctan-2-One%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D993%26epage%3D998%26doi%3D10.1016%2Fj.tetasy.2006.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Riguet, E.</span><span> </span><span class="NLM_article-title">Novel Guanidinyl Pyrrolidine Salt-Based Bifunctional Organocatalysts: Application in Asymmetric Conjugate Addition of Malonates to Enones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4283</span><span class="NLM_x">–</span> <span class="NLM_lpage">4285</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2Fj.tetlet.2009.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=4283-4285&author=E.+Riguet&title=Novel+Guanidinyl+Pyrrolidine+Salt-Based+Bifunctional+Organocatalysts%3A+Application+in+Asymmetric+Conjugate+Addition+of+Malonates+to+Enones&doi=10.1016%2Fj.tetlet.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DRiguet%26aufirst%3DE.%26atitle%3DNovel%2520Guanidinyl%2520Pyrrolidine%2520Salt-Based%2520Bifunctional%2520Organocatalysts%253A%2520Application%2520in%2520Asymmetric%2520Conjugate%2520Addition%2520of%2520Malonates%2520to%2520Enones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D4283%26epage%3D4285%26doi%3D10.1016%2Fj.tetlet.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wascholowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C. E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. V.</span><span> </span><span class="NLM_article-title">A General Organocatalytic Enantioselective Malonate Addition to α,β-Unsaturated Enones</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6155</span><span class="NLM_x">–</span> <span class="NLM_lpage">6165</span><span class="refDoi"> DOI: 10.1002/chem.200800673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fchem.200800673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=18512863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVOgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6155-6165&author=V.+Wascholowskiauthor=K.+R.+Knudsenauthor=C.+E.+T.+Mitchellauthor=S.+V.+Ley&title=A+General+Organocatalytic+Enantioselective+Malonate+Addition+to+%CE%B1%2C%CE%B2-Unsaturated+Enones&doi=10.1002%2Fchem.200800673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A general organocatalytic enantioselective malonate addition to α,β-unsaturated enones</span></div><div class="casAuthors">Wascholowski, Veit; Knudsen, Kristian Rahbek; Mitchell, Claire E. T.; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6155-6165</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A general enantioselective organocatalytic conjugate addn. procedure of a variety of malonates to α,β-unsatd. enone systems is presented.  The reaction is efficiently catalyzed by the pyrrolidinyl tetrazole catalyst.  Cyclic, acyclic and arom. enones can be used and the reaction with Et malonates provides the Michael addn. products in high yields with good to excellent enantioselectivities.  Since only 1.5 equiv of malonate are used as a reagent, the reaction is readily scaled and practical to operate.  Furthermore, the malonate addn. products can be easily mono decarboxylated without loss in enantiomeric excess by enzymic or sodium hydroxide mediated methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp75lIycCnFprVg90H21EOLACvtfcHk0lg-noz_Y8mz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVOgsbs%253D&md5=6da3d568b3f6505ed18fd76b53214869</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.200800673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200800673%26sid%3Dliteratum%253Aachs%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DKnudsen%26aufirst%3DK.%2BR.%26aulast%3DMitchell%26aufirst%3DC.%2BE.%2BT.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DA%2520General%2520Organocatalytic%2520Enantioselective%2520Malonate%2520Addition%2520to%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Enones%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D6155%26epage%3D6165%26doi%3D10.1002%2Fchem.200800673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Peters, W.</span> In  <span class="citation_source-book">Chemotherapy and Drug Resistance in Malaria</span>; <span class="NLM_publisher-name">Academic Press, Inc.</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">1987</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=145-273&author=W.+Peters&title=Chemotherapy+and+Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DW.%26btitle%3DChemotherapy%2520and%2520Drug%2520Resistance%2520in%2520Malaria%26pub%3DAcademic%2520Press%252C%2520Inc%26date%3D1987%26spage%3D145%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1021/jm901473s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901473s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=481-491&author=Y.+Dongauthor=S.+Wittlinauthor=K.+Sriraghavanauthor=J.+Cholletauthor=S.+A.+Charmanauthor=W.+N.+Charmanauthor=C.+Scheurerauthor=H.+Urwylerauthor=J.+Santo+Tomasauthor=C.+Snyderauthor=D.+J.+Creekauthor=J.+Morizziauthor=M.+Koltunauthor=H.+Matileauthor=X.+Wangauthor=M.+Padmanilayamauthor=Y.+Tangauthor=A.+Dornauthor=R.+Brunauthor=J.+L.+Vennerstrom&title=The+Structure-Activity+Relationship+of+the+Antimalarial+Ozonide+Arterolane+%28OZ277%29&doi=10.1021%2Fjm901473s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm901473s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901473s%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520Structure-Activity%2520Relationship%2520of%2520the%2520Antimalarial%2520Ozonide%2520Arterolane%2520%2528OZ277%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D481%26epage%3D491%26doi%3D10.1021%2Fjm901473s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Vennerstrom, J. L.; Dong, Y.; Charman, S. A.; Wittlin, S.; Chollet, J.; Creek, D. J.; Wang, X.; Sriraghavan, K.; Zhou, L.; Matile, H.; Charman, W. N.</span><span> </span><span class="NLM_article-title">Dispiro 1,2,4-trioxolane Antimalarials</span>. PCT WO 2009/058859 A2, May 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+L.+Vennerstrom&author=Y.+Dong&author=S.+A.+Charman&author=S.+Wittlin&author=J.+Chollet&author=D.+J.+Creek&author=X.+Wang&author=K.+Sriraghavan&author=L.+Zhou&author=H.+Matile&author=W.+N.+Charman&title=Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DDispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amewu, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pidathala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljayyoussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturén, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazaga, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirjanata, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noviyanti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marfurt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinden, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochford, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocken, C. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeeman, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span> </span><span class="NLM_article-title">A Tetraoxane-Based Antimalarial Drug Candidate That Overcomes PfK13-C580Y Dependent Artemisinin Resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15159</span><span class="refDoi"> DOI: 10.1038/ncomms15159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fncomms15159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=28537265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15159&author=P.+M.+O%E2%80%99Neillauthor=R.+K.+Amewuauthor=S.+A.+Charmanauthor=S.+Sabbaniauthor=N.+F.+Gn%C3%A4digauthor=J.+Straimerauthor=D.+A.+Fidockauthor=E.+R.+Shoreauthor=N.+L.+Robertsauthor=M.+H.-L.+Wongauthor=W.+D.+Hongauthor=C.+Pidathalaauthor=C.+Rileyauthor=B.+Murphyauthor=G.+Aljayyoussiauthor=F.+J.+Gamoauthor=L.+Sanzauthor=J.+Rodriguesauthor=C.+G.+Cortesauthor=E.+Herrerosauthor=I.+Angulo-Bartur%C3%A9nauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+F.+Bazagaauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=B.+Campoauthor=R.+Sharmaauthor=E.+Ryanauthor=D.+M.+Shacklefordauthor=S.+Campbellauthor=D.+A.+Smithauthor=G.+Wirjanataauthor=R.+Noviyantiauthor=R.+N.+Priceauthor=J.+Marfurtauthor=M.+J.+Palmerauthor=I.+M.+Coppleauthor=A.+E.+Mercerauthor=A.+Rueckerauthor=M.+J.+Delvesauthor=R.+E.+Sindenauthor=P.+Sieglauthor=J.+Daviesauthor=R.+Rochfordauthor=C.+H.+M.+Kockenauthor=A.-M.+Zeemanauthor=G.+L.+Nixonauthor=G.+A.+Biaginiauthor=S.+A.+Ward&title=A+Tetraoxane-Based+Antimalarial+Drug+Candidate+That+Overcomes+PfK13-C580Y+Dependent+Artemisinin+Resistance&doi=10.1038%2Fncomms15159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance</span></div><div class="casAuthors">O'Neill, Paul M.; Amewu, Richard K.; Charman, Susan A.; Sabbani, Sunil; Gnadig, Nina F.; Straimer, Judith; Fidock, David A.; Shore, Emma R.; Roberts, Natalie L.; Wong, Michael H.-L.; Hong, W. David; Pidathala, Chandrakala; Riley, Chris; Murphy, Ben; Aljayyoussi, Ghaith; Gamo, Francisco Javier; Sanz, Laura; Rodrigues, Janneth; Cortes, Carolina Gonzalez; Herreros, Esperanza; Angulo-Barturen, Inigo; Jimenez-Diaz, Maria Belen; Bazaga, Santiago Ferrer; Martinez-Martinez, Maria Santos; Campo, Brice; Sharma, Raman; Ryan, Eileen; Shackleford, David M.; Campbell, Simon; Smith, Dennis A.; Wirjanata, Grennady; Noviyanti, Rintis; Price, Ric N.; Marfurt, Jutta; Palmer, Michael J.; Copple, Ian M.; Mercer, Amy E.; Ruecker, Andrea; Delves, Michael J.; Sinden, Robert E.; Siegl, Peter; Davies, Jill; Rochford, Rosemary; Kocken, Clemens H. M.; Zeeman, Anne-Marie; Nixon, Gemma L.; Biagini, Giancarlo A.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15159</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">K13 gene mutations are a primary marker of artemisinin resistance in Plasmodium falciparum malaria that threatens the long-term clin. utility of artemisinin-based combination therapies, the cornerstone of modern day malaria treatment.  Here we describe a multinational drug discovery program that has delivered a synthetic tetraoxane-based mol., E209, which meets key requirements of the Medicines for Malaria Venture drug candidate profiles.  E209 has potent nanomolar inhibitory activity against multiple strains of P. falciparum and P. vivax in vitro, is efficacious against P. falciparum in in vivo rodent models, produces parasite redn. ratios equiv. to dihydroartemisinin and has pharmacokinetic and pharmacodynamic characteristics compatible with a single-dose cure.  In vitro studies with transgenic parasites expressing variant forms of K13 show no cross-resistance with the C580Y mutation, the primary variant obsd. in Southeast Asia.  E209 is a superior next generation endoperoxide with combined pharmacokinetic and pharmacodynamic features that overcome the liabilities of artemisinin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy5gsI57-l8rVg90H21EOLACvtfcHk0lg23EsENgbucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12gsb8%253D&md5=652486b04d3bf715b07ccf76c6226db0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fncomms15159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15159%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DAmewu%26aufirst%3DR.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DSabbani%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DShore%26aufirst%3DE.%2BR.%26aulast%3DRoberts%26aufirst%3DN.%2BL.%26aulast%3DWong%26aufirst%3DM.%2BH.-L.%26aulast%3DHong%26aufirst%3DW.%2BD.%26aulast%3DPidathala%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DB.%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DC.%2BG.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DAngulo-Bartur%25C3%25A9n%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DBazaga%26aufirst%3DS.%2BF.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DA%2520Tetraoxane-Based%2520Antimalarial%2520Drug%2520Candidate%2520That%2520Overcomes%2520PfK13-C580Y%2520Dependent%2520Artemisinin%2520Resistance%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15159%26doi%3D10.1038%2Fncomms15159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sijwali, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span> </span><span class="NLM_article-title">Gene Disruption Confirms a Critical Role for the Cysteine Protease Falcipain-2 in Hemoglobin Hydrolysis by Plasmodium Falciparum</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4384</span><span class="NLM_x">–</span> <span class="NLM_lpage">4389</span><span class="refDoi"> DOI: 10.1073/pnas.0307720101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.0307720101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=15070727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4384-4389&author=P.+S.+Sijwaliauthor=P.+J.+Rosenthal&title=Gene+Disruption+Confirms+a+Critical+Role+for+the+Cysteine+Protease+Falcipain-2+in+Hemoglobin+Hydrolysis+by+Plasmodium+Falciparum&doi=10.1073%2Fpnas.0307720101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum</span></div><div class="casAuthors">Sijwali, Puran S.; Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4384-4389</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Erythrocytic malaria parasites degrade Hb in an acidic food vacuole to acquire free amino acids and maintain parasite homeostasis.  Hb hydrolysis appears to be a cooperative process requiring cysteine proteases (falcipains) and aspartic proteases (plasmepsins), but the specific roles of different enzymes in this process are unknown.  We previously showed that falcipain-2 is a major trophozoite food vacuole cysteine protease.  To characterize the specific role of falcipain-2, we disrupted the falcipain-2 gene and assessed the effect of this alteration.  Falcipain-2-knockout trophozoites had markedly diminished cysteine protease activity and swollen, dark staining food vacuoles, consistent with a block in Hb hydrolysis, as caused by cysteine protease inhibitors.  However, more mature stages of knockout parasites were indistinguishable from wild-type parasites and developed normally.  The knockout parasites had decreased and delayed expression of falcipain-2, which appeared to be directed by increased transcription of a 2nd copy of the gene (falcipain-2').  Expression of other falcipains and plasmepsins was similar in wild-type and knockout parasites.  Compared with wild-type, knockout parasites were ∼3-fold more sensitive to the cysteine protease inhibitors E-64 and leupeptin, and >50-fold more sensitive to the aspartic protease inhibitor pepstatin.  Our results assign a specific function for falcipain-2, the hydrolysis of Hb in trophozoites.  In addn., they highlight the cooperative action of cysteine and aspartic proteases in Hb degrdn. by malaria parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZW4wz_dvmZbVg90H21EOLACvtfcHk0lg23EsENgbucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKjur0%253D&md5=9e872338befb30d20d28da2fee29c729</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307720101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307720101%26sid%3Dliteratum%253Aachs%26aulast%3DSijwali%26aufirst%3DP.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DGene%2520Disruption%2520Confirms%2520a%2520Critical%2520Role%2520for%2520the%2520Cysteine%2520Protease%2520Falcipain-2%2520in%2520Hemoglobin%2520Hydrolysis%2520by%2520Plasmodium%2520Falciparum%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D4384%26epage%3D4389%26doi%3D10.1073%2Fpnas.0307720101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref31':['cit31'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Christopher M. Woodley, Gemma L. Nixon, Nicoletta Basilico, Silvia Parapini, Weiqian David Hong, Stephen A. Ward, Giancarlo A. Biagini, Suet C. Leung, Donatella Taramelli, Keiko Onuma, Takashi Hasebe, <span class="NLM_string-name hlFld-ContribAuthor">Paul M. O’Neill</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis and Profiling of Potent, Nonlinear Analogues of Antimalarial Tetraoxanes E209 and N205. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1077-1085. <a href="https://doi.org/10.1021/acsmedchemlett.1c00031" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00031%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnantioselective%252BSynthesis%252Band%252BProfiling%252Bof%252BPotent%25252C%252BNonlinear%252BAnalogues%252Bof%252BAntimalarial%252BTetraoxanes%252BE209%252Band%252BN205%26aulast%3DWoodley%26aufirst%3DChristopher%2BM.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18012021%26date%3D17062021%26date%3D24062021%26volume%3D12%26issue%3D7%26spage%3D1077%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brian R. Blank, Ryan L. Gonciarz, Poulami Talukder, Jiri Gut, Jennifer Legac, Philip J. Rosenthal, <span class="NLM_string-name hlFld-ContribAuthor">Adam R. Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Antimalarial Trioxolanes with Superior Drug-Like Properties and In Vivo Efficacy. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (7)
                                     , 1827-1835. <a href="https://doi.org/10.1021/acsinfecdis.0c00064" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAntimalarial%252BTrioxolanes%252Bwith%252BSuperior%252BDrug-Like%252BProperties%252Band%252BIn%252BVivo%252BEfficacy%26aulast%3DBlank%26aufirst%3DBrian%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11022020%26date%3D18052020%26date%3D05052020%26volume%3D6%26issue%3D7%26spage%3D1827%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Oxana B. Kazakova, Elmira F. Khusnutdinova, Anastasiya V. Petrova, Emil Yu. Yamansarov, Alexander N. Lobov, Alexandra A. Fedorova, <span class="NLM_string-name hlFld-ContribAuthor">Kyrill Yu. Suponitsky</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of Triterpenoid 1,2,4-Trioxolanes by Griesbaum Co-ozonolysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2019,</strong> <em>82 </em>
                                    (9)
                                     , 2550-2558. <a href="https://doi.org/10.1021/acs.jnatprod.9b00393" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.9b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.9b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.9b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252BTriterpenoid%252B1%25252C2%25252C4-Trioxolanes%252Bby%252BGriesbaum%252BCo-ozonolysis%26aulast%3DKazakova%26aufirst%3DOxana%2BB.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02052019%26date%3D06092019%26volume%3D82%26issue%3D9%26spage%3D2550%26epage%3D2558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manu Anantpadma, Thomas Lane, Kimberley M. Zorn, Mary A. Lingerfelt, Alex M. Clark, Joel S. Freundlich, Robert A. Davey, Peter B. Madrid, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 2353-2361. <a href="https://doi.org/10.1021/acsomega.8b02948" title="DOI URL">https://doi.org/10.1021/acsomega.8b02948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02948%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEbola%252BVirus%252BBayesian%252BMachine%252BLearning%252BModels%252BEnable%252BNew%252Bin%252BVitro%252BLeads%26aulast%3DAnantpadma%26aufirst%3DManu%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D25102018%26date%3D17012019%26volume%3D4%26issue%3D1%26spage%3D2353%26epage%3D2361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin Spangler, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, James A. Wells, Aaron K. Sato, <span class="NLM_string-name hlFld-ContribAuthor">Adam R. Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (5)
                                     , 2054-2059. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00242" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00242%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DToward%252Ba%252BFerrous%252BIron-Cleavable%252BLinker%252Bfor%252BAntibody%2525E2%252580%252593Drug%252BConjugates%26aulast%3DSpangler%26aufirst%3DBenjamin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06032018%26date%3D18032018%26date%3D23032018%26volume%3D15%26issue%3D5%26spage%3D2054%26epage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Jian-Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Heng-Ye  Xiang</span>, <span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Tong-Mei  Ding</span>, and <span class="hlFld-ContribAuthor ">Shu-Yu  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Mediated Cascade C–H/N–H Annulation of Indolocarboxamides with Arynes: Construction of Tetracyclic Indoloquinoline Alkaloids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (1)
                                     , 220-223. <a href="https://doi.org/10.1021/acs.orglett.7b03580" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03580%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Mediated%252BCascade%252BC%2525E2%252580%252593H%25252FN%2525E2%252580%252593H%252BAnnulation%252Bof%252BIndolocarboxamides%252Bwith%252BArynes%25253A%252BConstruction%252Bof%252BTetracyclic%252BIndoloquinoline%252BAlkaloids%26aulast%3DZhang%26aufirst%3DTing-Yu%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D17112017%26date%3D08122017%26date%3D05012018%26volume%3D20%26issue%3D1%26spage%3D220%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keng Yoon  Yeong</span>, <span class="hlFld-ContribAuthor ">Liam  Stephens</span>, <span class="hlFld-ContribAuthor ">Irene  Ling</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Rings With Three Oxygen or Sulfur Atoms in 1,2,4-Positions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00050-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00050-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00050-0%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRings%252BWith%252BThree%252BOxygen%252Bor%252BSulfur%252BAtoms%252Bin%252B1%25252C2%25252C4-Positions%26aulast%3DYeong%26aufirst%3DKeng%2BYoon%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah Louise  Rawe</span>. </span><span class="cited-content_cbyCitation_article-title">Artemisinin and artemisinin-related agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 99-132. <a href="https://doi.org/10.1016/B978-0-08-101210-9.00004-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-101210-9.00004-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101210-9.00004-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101210-9.00004-4%26sid%3Dliteratum%253Aachs%26atitle%3DArtemisinin%252Band%252Bartemisinin-related%252Bagents%26aulast%3DRawe%26aufirst%3DSarah%2BLouise%26date%3D2020%26spage%3D99%26epage%3D132%26pub%3DElsevier%26atitle%3DAntimalarial%252BAgents%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit K.  Tiwari</span>, <span class="hlFld-ContribAuthor ">Dharmendra K.  Yadav</span>, <span class="hlFld-ContribAuthor ">Sandeep  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (10)
                                     , 831-846. <a href="https://doi.org/10.2174/1568026619666190412104042" title="DOI URL">https://doi.org/10.2174/1568026619666190412104042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190412104042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190412104042%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BDevelopments%252Bin%252BNatural%252BProduct%252BInspired%252BSynthetic%252B1%25252C2%25252C4-%252BTrioxolanes%252B%252528Ozonides%252529%25253A%252BAn%252BUnusual%252BEntry%252Binto%252BAntimalarial%252BChemotherapy%26aulast%3DTiwari%26aufirst%3DMohit%2BK.%26date%3D2019%26volume%3D19%26issue%3D10%26spage%3D831%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey  Schwertz</span>, <span class="hlFld-ContribAuthor ">Matthias C.  Witschel</span>, <span class="hlFld-ContribAuthor ">Matthias  Rottmann</span>, <span class="hlFld-ContribAuthor ">Ubolsree  Leartsakulpanich</span>, <span class="hlFld-ContribAuthor ">Penchit  Chitnumsub</span>, <span class="hlFld-ContribAuthor ">Aritsara  Jaruwat</span>, <span class="hlFld-ContribAuthor ">Watcharee  Amornwatcharapong</span>, <span class="hlFld-ContribAuthor ">Wanwipa  Ittarat</span>, <span class="hlFld-ContribAuthor ">Anja  Schäfer</span>, <span class="hlFld-ContribAuthor ">Raphael A.  Aponte</span>, <span class="hlFld-ContribAuthor ">Nils  Trapp</span>, <span class="hlFld-ContribAuthor ">Pimchai  Chaiyen</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of
              Plasmodial
              Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 931-943. <a href="https://doi.org/10.1002/cmdc.201800053" title="DOI URL">https://doi.org/10.1002/cmdc.201800053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800053%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPotent%252BInhibitors%252Bof%252BPlasmodial%252BSerine%252BHydroxymethyltransferase%252B%252528SHMT%252529%252BFeaturing%252Ba%252BSpirocyclic%252BScaffold%26aulast%3DSchwertz%26aufirst%3DGeoffrey%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Alan  Aitken</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 263-278. <a href="https://doi.org/10.1016/B978-0-08-102788-2.00010-6" title="DOI URL">https://doi.org/10.1016/B978-0-08-102788-2.00010-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102788-2.00010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102788-2.00010-6%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DAitken%26aufirst%3DR.%2BAlan%26date%3D2018%26spage%3D263%26epage%3D278%26pub%3DElsevier%26date%3D2018%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed  Badshah</span>, <span class="hlFld-ContribAuthor ">Asad  Ullah</span>, <span class="hlFld-ContribAuthor ">Nasir  Ahmad</span>, <span class="hlFld-ContribAuthor ">Zainab  Almarhoon</span>, <span class="hlFld-ContribAuthor ">Yahia  Mabkhot</span>. </span><span class="cited-content_cbyCitation_article-title">Increasing the Strength and Production of Artemisinin and Its Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (1)
                                     , 100. <a href="https://doi.org/10.3390/molecules23010100" title="DOI URL">https://doi.org/10.3390/molecules23010100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23010100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23010100%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIncreasing%252Bthe%252BStrength%252Band%252BProduction%252Bof%252BArtemisinin%252Band%252BIts%252BDerivatives%26aulast%3DBadshah%26aufirst%3DSyed%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of antimalarial endoperoxides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Conformational Effects on Fe(II) Reactivity in Antimalarial 1,2,4-Trioxolanes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Arterolane and Related <i>cis</i>-4″ Analogues from Key Intermediate <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 75 min; R(R′)NH, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C to rt, 2–24 h, 71–95%. Reaction conditions adapted from ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Enantiocontrolled Synthesis of Ketone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl malonate, (<i>R</i>)-ALB (1 mol %), <i>t</i>-BuOK (0.9 equiv relative to ALB), 4 Å MS, THF, rt, 68 h, 87%; (b) NaOH, H<sub>2</sub>O/THF (11:1), 0 °C, 2 h; (c) DMSO, 160 °C, 4 h, 85% over two steps.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Stereocontrolled Synthesis of 1,2,4-Trioxolane Analogues <b>12a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 0.5 equiv of <b>7</b>, O<sub>3</sub>, CCl<sub>4</sub>, 0 °C, 3 h, 95%; (b) NaOH, EtOH/H<sub>2</sub>O, 50 °C, 4 h, 95%; (c) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 75 min; R(R′)NH, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C to rt, 2–24 h, 68–95%.</p></p></figure><figure data-id="cht1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/medium/jm-2017-006994_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. In Vitro Activity of Trioxolanes <b>12a</b>–<b>j</b> and <b>2a</b>–<b>j</b> against W2 <i>P. falciparum</i> Parasites<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00699/20170721/images/large/jm-2017-006994_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00699&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>In vitro activity of <b>12a</b>–<b>j</b> and <b>2a</b>–<b>j</b> against W2 <i>P. falciparum</i> parasites (EC<sub>50</sub> ± SEM). Reported EC<sub>50</sub> values are the means of three determinations ± SEM</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Posner, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C. H.</span><span> </span><span class="NLM_article-title">A Regiospecifically Oxygen-18 Labeled 1, 2, 4-Trioxane: A Simple Chemical Model System To Probe the Mechanism(s) for the Antimalarial Activity of Artemisinin (Qinghaosu)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">8328</span><span class="NLM_x">–</span> <span class="NLM_lpage">8329</span><span class="refDoi"> DOI: 10.1021/ja00047a076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00047a076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=8328-8329&author=G.+H.+Posnerauthor=C.+H.+Oh&title=A+Regiospecifically+Oxygen-18+Labeled+1%2C+2%2C+4-Trioxane%3A+A+Simple+Chemical+Model+System+To+Probe+the+Mechanism%28s%29+for+the+Antimalarial+Activity+of+Artemisinin+%28Qinghaosu%29&doi=10.1021%2Fja00047a076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fja00047a076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00047a076%26sid%3Dliteratum%253Aachs%26aulast%3DPosner%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DC.%2BH.%26atitle%3DA%2520Regiospecifically%2520Oxygen-18%2520Labeled%25201%252C%25202%252C%25204-Trioxane%253A%2520A%2520Simple%2520Chemical%2520Model%2520System%2520To%2520Probe%2520the%2520Mechanism%2528s%2529%2520for%2520the%2520Antimalarial%2520Activity%2520of%2520Artemisinin%2520%2528Qinghaosu%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D8328%26epage%3D8329%26doi%3D10.1021%2Fja00047a076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Posner, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhous, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshnick, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asawamahasadka, W.</span><span> </span><span class="NLM_article-title">Mechanism-Based Design, Synthesis and in Vitro Antimalarial Testing of New 4-Methylated Trioxanes Structurally Related to Artemisinin: The Importance of a Carbon-Centered Radical for Antimalarial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1021/jm00035a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00035a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1256-1258&author=G.+H.+Posnerauthor=C.+H.+Ohauthor=D.+Wangauthor=L.+Gerenaauthor=W.+K.+Milhousauthor=S.+R.+Meshnickauthor=W.+Asawamahasadka&title=Mechanism-Based+Design%2C+Synthesis+and+in+Vitro+Antimalarial+Testing+of+New+4-Methylated+Trioxanes+Structurally+Related+to+Artemisinin%3A+The+Importance+of+a+Carbon-Centered+Radical+for+Antimalarial+Activity&doi=10.1021%2Fjm00035a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00035a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00035a003%26sid%3Dliteratum%253Aachs%26aulast%3DPosner%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DMilhous%26aufirst%3DW.%2BK.%26aulast%3DMeshnick%26aufirst%3DS.%2BR.%26aulast%3DAsawamahasadka%26aufirst%3DW.%26atitle%3DMechanism-Based%2520Design%252C%2520Synthesis%2520and%2520in%2520Vitro%2520Antimalarial%2520Testing%2520of%2520New%25204-Methylated%2520Trioxanes%2520Structurally%2520Related%2520to%2520Artemisinin%253A%2520The%2520Importance%2520of%2520a%2520Carbon-Centered%2520Radical%2520for%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1256%26epage%3D1258%26doi%3D10.1021%2Fjm00035a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorneaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Identification of an Antimalarial Synthetic Trioxolane Drug Development Candidate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/nature02779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fnature02779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=15318224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=900-904&author=J.+L.+Vennerstromauthor=S.+Arbe-Barnesauthor=R.+Brunauthor=S.+A.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=Y.+Dongauthor=A.+Dornauthor=D.+Hunzikerauthor=H.+Matileauthor=K.+McIntoshauthor=M.+Padmanilayamauthor=J.+Santo+Tomasauthor=C.+Scheurerauthor=B.+Scorneauxauthor=Y.+Tangauthor=H.+Urwylerauthor=S.+Wittlinauthor=W.+N.+Charman&title=Identification+of+an+Antimalarial+Synthetic+Trioxolane+Drug+Development+Candidate&doi=10.1038%2Fnature02779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an antimalarial synthetic trioxolane drug development candidate</span></div><div class="casAuthors">Vennerstrom, Jonathan L.; Arbe-Barnes, Sarah; Brun, Reto; Charman, Susan A.; Chiu, Francis C. K.; Chollet, Jacques; Dong, Yuxiang; Dorn, Arnulf; Hunziker, Daniel; Matile, Hugues; McIntosh, Kylie; Padmanilayam, Maniyan; Santo Tomas, Josefina; Scheurer, Christian; Scorneaux, Bernard; Tang, Yuanqing; Urwyler, Heinrich; Wittlin, Sergio; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7002</span>),
    <span class="NLM_cas:pages">900-904</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of artemisinin more than 30 yr ago provided a completely new antimalarial structural prototype; i.e., a mol. with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle.  Available evidence suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by hem, released as a result of Hb digestion by the malaria-causing parasite.  This irreversible redox reaction produces carbon-centered free radicals, leading to alkylation of hem and proteins (enzymes), one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be crit. to parasite survival.  Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs.  The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indexes and provide for successful treatment outcomes.  However, as a drug class, the artemisinins suffer from chem. (semi-synthetic availability, purity and cost), biopharmaceutical (poor bioavailability and limiting pharmacokinetics) and treatment (noncompliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential.  Here the authors describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwBOuKiqjSbVg90H21EOLACvtfcHk0lhpvhU5j9SbyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D&md5=71070255d32c12fe3c227d5091225b31</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature02779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02779%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DHunziker%26aufirst%3DD.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DIdentification%2520of%2520an%2520Antimalarial%2520Synthetic%2520Trioxolane%2520Drug%2520Development%2520Candidate%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D900%26epage%3D904%26doi%3D10.1038%2Fnature02779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papastogiannidis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingelin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Synthetic Ozonide Drug Candidate OZ439 Offers New Hope for a Single-Dose Cure of Uncomplicated Malaria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span><span class="refDoi"> DOI: 10.1073/pnas.1015762108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.1015762108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=21300861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=4400-4405&author=S.+A.+Charmanauthor=S.+Arbe-Barnesauthor=I.+C.+Bathurstauthor=R.+Brunauthor=M.+Campbellauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=J.+C.+Craftauthor=D.+J.+Creekauthor=Y.+Dongauthor=H.+Matileauthor=M.+Maurerauthor=J.+Morizziauthor=T.+Nguyenauthor=P.+Papastogiannidisauthor=C.+Scheurerauthor=D.+M.+Shacklefordauthor=K.+Sriraghavanauthor=L.+Stingelinauthor=Y.+Tangauthor=H.+Urwylerauthor=X.+Wangauthor=K.+L.+Whiteauthor=S.+Wittlinauthor=L.+Zhouauthor=J.+L.+Vennerstrom&title=Synthetic+Ozonide+Drug+Candidate+OZ439+Offers+New+Hope+for+a+Single-Dose+Cure+of+Uncomplicated+Malaria&doi=10.1073%2Fpnas.1015762108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span></div><div class="casAuthors">Charman, Susan A.; Arbe-Barnes, Sarah; Bathurst, Ian C.; Brun, Reto; Campbell, Michael; Charman, William N.; Chiu, Francis C. K.; Chollet, Jacques; Craft, J. Carl; Creek, Darren J.; Dong, Yuxiang; Matile, Hugues; Maurer, Melanie; Morizzi, Julia; Nguyen, Tien; Papastogiannidis, Petros; Scheurer, Christian; Shackleford, David M.; Sriraghavan, Kamaraj; Stingelin, Lukas; Tang, Yuanqing; Urwyler, Heinrich; Wang, Xiaofang; White, Karen L.; Wittlin, Sergio; Zhou, Lin; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4400-4405, S4400/1-S4400/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ozonide OZ439 is a synthetic peroxide antimalarial drug candidate designed to provide a single-dose oral cure in humans.  OZ439 has successfully completed Phase I clin. trials, where it was shown to be safe at doses up to 1,600 mg and is currently undergoing Phase Ila trials in malaria patients.  Herein, we describe the discovery of OZ439 and the exceptional antimalarial and pharmacokinetic properties that led to its selection as a clin. drug development candidate.  In vitro, OZ439 is fast-acting against all asexual erythrocytic Plasmodium falciparum stages with ICs0 values comparable to those for the clin. used artemisinin derivs.  Unlike all other synthetic peroxides and semisynthetic artemisinin derivs., OZ439 completely cures Plasmodium berghei-infected mice with a single oral dose of 20 mg/kg and exhibits prophylactic activity superior to that of the benchmark chemoprophylactic agent, mefloquine.  Compared with other peroxide-contg. antimalarial agents, such as the artemisinin derivs. and the first-generation ozonide OZ277, OZ439 exhibits a substantial increase in the pharmacokinetic half-life and blood concn. vs. time profile in three preclin. species.  The outstanding efficacy and prolonged blood concns. of OZ439 are the result of a design strategy that stabilizes the intrinsically unstable pharmacophoric peroxide bond, thereby reducing clearance yet maintaining the necessary Fe(II)-reactivity to elicit parasite death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxoUteI8z2bVg90H21EOLACvtfcHk0lhpvhU5j9SbyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D&md5=5da13be1d57a8dd58b21246814f6c268</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015762108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015762108%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBathurst%26aufirst%3DI.%2BC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DStingelin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSynthetic%2520Ozonide%2520Drug%2520Candidate%2520OZ439%2520Offers%2520New%2520Hope%2520for%2520a%2520Single-Dose%2520Cure%2520of%2520Uncomplicated%2520Malaria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D4400%26epage%3D4405%26doi%3D10.1073%2Fpnas.1015762108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Moehrle, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duparc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siethoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Giersbergen, P. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">First-in-Man Safety and Pharmacokinetics of Synthetic Ozonide OZ439 Demonstrates an Improved Exposure Profile Relative to Other Peroxide Antimalarials</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04368.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1111%2Fj.1365-2125.2012.04368.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=22759078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1KksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=524-537&author=J.+J.+Moehrleauthor=S.+Duparcauthor=C.+Siethoffauthor=P.+L.+M.+van+Giersbergenauthor=J.+C.+Craftauthor=S.+Arbe-Barnesauthor=S.+A.+Charmanauthor=M.+Gutierrezauthor=S.+Wittlinauthor=J.+L.+Vennerstrom&title=First-in-Man+Safety+and+Pharmacokinetics+of+Synthetic+Ozonide+OZ439+Demonstrates+an+Improved+Exposure+Profile+Relative+to+Other+Peroxide+Antimalarials&doi=10.1111%2Fj.1365-2125.2012.04368.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials</span></div><div class="casAuthors">Moehrle, Joerg J.; Duparc, Stephan; Siethoff, Christoph; van Giersbergen, Paul L. M.; Craft, J. Carl; Arbe-Barnes, Sarah; Charman, Susan A.; Gutierrez, Maria; Wittlin, Sergio; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-537</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess the safety and pharmacokinetics of a new synthetic ozonide antimalarial, OZ439, in a first-in-man, double-blind study in healthy volunteers.  OZ439 was administered as single oral daily doses of a capsule formulation (50-1200 mg) or an oral dispersion (400-1600 mg, fed and fasted states) and for up to 3 days as an oral dispersion (200-800 mg day-1).  Plasma concns. of OZ439 and its metabolites were measured by LC-MS.  The pharmacokinetic (PK) profile of OZ439 was characterized by a tmax of around 3 h, followed by a multiphasic profile with a terminal half-life of 25-30 h.  The PK parameters were approx. dose proportional for each group and profiles of the metabolites followed a similar pattern to that of the parent compd.  Following dosing for 3 days, accumulation was less than two-fold but steady-state was not achieved.  In the presence of food, no effect was obsd. on the t1/2 of OZ439 while the exposure was increased by 3 to 4.5-fold.  Exposure was higher and inter-subject variability was reduced when OZ439 was administered as an oral dispersion compared with a capsule.  The urinary clearance of OZ439 and its metabolites was found to be negligible and OZ439 did not induce CYP3A4.  The antimalarial activity profiles of a subset of serum samples suggested that the major antimalarial activity originated from OZ439 rather than from any of the metabolites.  The safety and pharmacokinetic profile of OZ439 merits progression to phase 2a proof of concept studies in the target population of acute uncomplicated malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz6xjkmmkaUbVg90H21EOLACvtfcHk0lhevaRgl81szg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1KksA%253D%253D&md5=703c3e1cd02a888e2e282ae1b7fbaf8a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04368.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04368.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DSiethoff%26aufirst%3DC.%26aulast%3Dvan%2BGiersbergen%26aufirst%3DP.%2BL.%2BM.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DFirst-in-Man%2520Safety%2520and%2520Pharmacokinetics%2520of%2520Synthetic%2520Ozonide%2520OZ439%2520Demonstrates%2520an%2520Improved%2520Exposure%2520Profile%2520Relative%2520to%2520Other%2520Peroxide%2520Antimalarials%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D524%26epage%3D537%26doi%3D10.1111%2Fj.1365-2125.2012.04368.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Phyo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jittamala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pukrittayakamee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imwong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duparc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möhrle, J. J.</span><span> </span><span class="NLM_article-title">Antimalarial Activity of Artefenomel (OZ439), a Novel Synthetic Antimalarial Endoperoxide, in Patients with Plasmodium Falciparum and Plasmodium Vivax Malaria: An Open-Label Phase 2 Trial</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)00320-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS1473-3099%2815%2900320-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26448141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wjs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=61-69&author=A.+P.+Phyoauthor=P.+Jittamalaauthor=F.+H.+Nostenauthor=S.+Pukrittayakameeauthor=M.+Imwongauthor=N.+J.+Whiteauthor=S.+Duparcauthor=F.+Macintyreauthor=M.+Bakerauthor=J.+J.+M%C3%B6hrle&title=Antimalarial+Activity+of+Artefenomel+%28OZ439%29%2C+a+Novel+Synthetic+Antimalarial+Endoperoxide%2C+in+Patients+with+Plasmodium+Falciparum+and+Plasmodium+Vivax+Malaria%3A+An+Open-Label+Phase+2+Trial&doi=10.1016%2FS1473-3099%2815%2900320-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial</span></div><div class="casAuthors">Phyo, Aung Pyae; Jittamala, Podjanee; Nosten, Francois H.; Pukrittayakamee, Sasithon; Imwong, Mallika; White, Nicholas J.; Duparc, Stephan; MacIntyre, Fiona; Baker, Mark; Mohrle, Jorg J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artefenomel (OZ439) is a novel synthetic trioxolane with improved pharmacokinetic properties compared with other antimalarial drugs with the artemisinin pharmacophore.  Artefenomel has been generally well tolerated in volunteers at doses up to 1600 mg and is being developed as a partner drug in an antimalarial combination treatment.  We investigated the efficacy, tolerability, and pharmacokinetics of artefenomel at different doses in patients with Plasmodium falciparum or Plasmodium vivax malaria.  This phase 2a exploratory, open-label trial was done at the Hospital for Tropical Diseases, Bangkok, and the Shoklo Malaria Research Unit in Thailand.  Adult patients with acute, uncomplicated P falciparum or P vivax malaria received artefenomel in a single oral dose (200 mg, 400 mg, 800 mg, or 1200 mg).  The first cohort received 800 mg.  Testing of a new dose of artefenomel in a patient cohort was decided on after safety and efficacy assessment of the preceding cohort.  The primary endpoint was the natural log parasite redn. per 24 h.  Definitive oral treatment was given at 36 h.  This trial is registered with ClinicalTrials.gov, no. NCT01213966.  Between Oct 24, 2010, and May 25, 2012, 82 patients were enrolled (20 in each of the 200 mg, 400 mg, and 800 mg cohorts, and 21 in the 1200 mg cohort).  One patient withdrew consent (before the administration of artefenomel) but there were no further dropouts.  The parasite redn. rates per 24 h ranged from 0·90 to 1·88 for P falciparum, and 2·09 to 2·53 for P vivax.  All doses were equally effective in both P falciparum and P vivax malaria, with median parasite clearance half-lives of 4·1 h (range 1·3-6·7) to 5·6 h (2·0-8·5) for P falciparum and 2·3 h (1·2-3·9) to 3·2 h (0·9-15·0) for P vivax.  Maximum plasma concns., dose-proportional to 800 mg, occurred at 4 h (median).  The estd. elimination half-life was 46-62 h.  No serious drug-related adverse effects were reported; other adverse effects were generally mild and reversible, with the highest no. in the 1200 mg cohort (17 [81%] patients with at least one adverse event).  The most frequently reported adverse effect was an asymptomatic increase in plasma creatine phosphokinase concn. (200 mg, n=5; 400 mg, n=3; 800 mg, n=1; 1200 mg, n=3).  Artefenomel is a new synthetic antimalarial peroxide with a good safety profile that clears parasitemia rapidly in both P falciparum and P vivax malaria.  Its long half-life suggests a possible use in a single-dose treatment in combination with other drugs.  Bill & Melinda Gates Foundation, Wellcome Trust, and UK Department for International Development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_OEYJuv5VVrVg90H21EOLACvtfcHk0lhevaRgl81szg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wjs7vP&md5=368550e5ec73242c603c8abdc6a66f12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900320-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900320-5%26sid%3Dliteratum%253Aachs%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DNosten%26aufirst%3DF.%2BH.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26atitle%3DAntimalarial%2520Activity%2520of%2520Artefenomel%2520%2528OZ439%2529%252C%2520a%2520Novel%2520Synthetic%2520Antimalarial%2520Endoperoxide%252C%2520in%2520Patients%2520with%2520Plasmodium%2520Falciparum%2520and%2520Plasmodium%2520Vivax%2520Malaria%253A%2520An%2520Open-Label%2520Phase%25202%2520Trial%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D61%26epage%3D69%26doi%3D10.1016%2FS1473-3099%2815%2900320-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ismail, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charoensutthivarakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span> </span><span class="NLM_article-title">A Click Chemistry-Based Proteomic Approach Reveals That 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">6511</span><span class="NLM_x">–</span> <span class="NLM_lpage">6515</span><span class="refDoi"> DOI: 10.1002/ange.201512062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fange.201512062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=6511-6515&author=H.+M.+Ismailauthor=V.+E.+Bartonauthor=M.+Panchanaauthor=S.+Charoensutthivarakulauthor=G.+A.+Biaginiauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=A+Click+Chemistry-Based+Proteomic+Approach+Reveals+That+1%2C2%2C4-Trioxolane+and+Artemisinin+Antimalarials+Share+a+Common+Protein+Alkylation+Profile&doi=10.1002%2Fange.201512062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fange.201512062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.201512062%26sid%3Dliteratum%253Aachs%26aulast%3DIsmail%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DV.%2BE.%26aulast%3DPanchana%26aufirst%3DM.%26aulast%3DCharoensutthivarakul%26aufirst%3DS.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DA%2520Click%2520Chemistry-Based%2520Proteomic%2520Approach%2520Reveals%2520That%25201%252C2%252C4-Trioxolane%2520and%2520Artemisinin%2520Antimalarials%2520Share%2520a%2520Common%2520Protein%2520Alkylation%2520Profile%26jtitle%3DAngew.%2520Chem.%26date%3D2016%26volume%3D128%26spage%3D6511%26epage%3D6515%26doi%3D10.1002%2Fange.201512062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ismail, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phanchana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charoensutthivarakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemingway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span> </span><span class="NLM_article-title">Artemisinin Activity-Based Probes Identify Multiple Molecular Targets within the Asexual Stage of the Malaria Parasites Plasmodium Falciparum 3D7</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2080</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span><span class="refDoi"> DOI: 10.1073/pnas.1600459113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.1600459113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26858419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit12ktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=2080-2085&author=H.+M.+Ismailauthor=V.+Bartonauthor=M.+Phanchanaauthor=S.+Charoensutthivarakulauthor=M.+H.+L.+Wongauthor=J.+Hemingwayauthor=G.+A.+Biaginiauthor=P.+M.+O%E2%80%99Neillauthor=S.+A.+Ward&title=Artemisinin+Activity-Based+Probes+Identify+Multiple+Molecular+Targets+within+the+Asexual+Stage+of+the+Malaria+Parasites+Plasmodium+Falciparum+3D7&doi=10.1073%2Fpnas.1600459113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7</span></div><div class="casAuthors">Ismail, Hanafy M.; Barton, Victoria; Phanchana, Matthew; Charoensutthivarakul, Sitthivut; Wong, Michael H. L.; Hemingway, Janet; Biagini, Giancarlo A.; O'Neill, Paul M.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2080-2085</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The artemisinin (ART)-based antimalarials have contributed significantly to reducing global malaria deaths over the past decade, but the authors still do not know how they kill parasites.  To gain greater insight into the potential mechanisms of ART drug action, the authors developed a suite of ART activity-based protein profiling probes to identify parasite protein drug targets in situ.  Probes were designed to retain biol. activity and alkylate the mol. target(s) of Plasmodium falciparum 3D7 parasites in situ.  Proteins tagged with the ART probe can then be isolated using click chem. before identification by liq. chromatog.-MS/MS.  Using these probes, the authors define an ART proteome that shows alkylated targets in the glycolytic, Hb degrdn., antioxidant defense, and protein synthesis pathways, processes essential for parasite survival.  This work reveals the pleiotropic nature of the biol. functions targeted by this important class of antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe38he4JorxrVg90H21EOLACvtfcHk0liB19EzxXx8TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit12ktb8%253D&md5=50a46614e45c5e2e7c819675679ec4a1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1600459113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1600459113%26sid%3Dliteratum%253Aachs%26aulast%3DIsmail%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DV.%26aulast%3DPhanchana%26aufirst%3DM.%26aulast%3DCharoensutthivarakul%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%2BH.%2BL.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DArtemisinin%2520Activity-Based%2520Probes%2520Identify%2520Multiple%2520Molecular%2520Targets%2520within%2520the%2520Asexual%2520Stage%2520of%2520the%2520Malaria%2520Parasites%2520Plasmodium%2520Falciparum%25203D7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D2080%26epage%3D2085%26doi%3D10.1073%2Fpnas.1600459113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, C. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span> </span><span class="NLM_article-title">Haem-Activated Promiscuous Targeting of Artemisinin in Plasmodium Falciparum</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">10111</span><span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.-J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Y.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.-X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.-C.+Huaauthor=B.+Liuauthor=H.-M.+Shenauthor=K.+S.+W.+Tanauthor=Q.+Lin&title=Haem-Activated+Promiscuous+Targeting+of+Artemisinin+in+Plasmodium+Falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0liB19EzxXx8TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.-J.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%2BY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.-X.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.-C.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.-M.%26aulast%3DTan%26aufirst%3DK.%2BS.%2BW.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-Activated%2520Promiscuous%2520Targeting%2520of%2520Artemisinin%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Try, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessborn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullo, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarning, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span> </span><span class="NLM_article-title">Dihydroartemisinin–Piperaquine Resistance in Plasmodium Falciparum Malaria in Cambodia: A Multisite Prospective Cohort Study</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)00487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS1473-3099%2815%2900487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=26774243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=357-365&author=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=C.+Sophaauthor=B.+Samauthor=D.+Dekauthor=V.+Tryauthor=R.+Amatoauthor=D.+Blessbornauthor=L.+Songauthor=G.+S.+Tulloauthor=M.+P.+Fayauthor=J.+M.+Andersonauthor=J.+Tarningauthor=R.+M.+Fairhurst&title=Dihydroartemisinin%E2%80%93Piperaquine+Resistance+in+Plasmodium+Falciparum+Malaria+in+Cambodia%3A+A+Multisite+Prospective+Cohort+Study&doi=10.1016%2FS1473-3099%2815%2900487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span></div><div class="casAuthors">Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Sopha, Chantha; Sam, Baramey; Dek, Dalin; Try, Vorleak; Amato, Roberto; Blessborn, Daniel; Song, Lijiang; Tullo, Gregory S.; Fay, Michael P.; Anderson, Jennifer M.; Tarning, Joel; Fairhurst, Rick M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria.  Recent treatment failures with dihydroartemisinin-piperaquine, the current first-line ACT in Cambodia, suggest that piperaquine resistance may be emerging in this country.  We explored the relation between artemisinin resistance and dihydroartemisinin-piperaquine failures, and sought to confirm the presence of piperaquine-resistant P falciparum infections in Cambodia.  In this prospective cohort study, we enrolled patients aged 2-65 years with uncomplicated P falciparum malaria in three Cambodian provinces: Pursat, Preah Vihear, and Ratanakiri.  Participants were given std. 3-day courses of dihydroartemisinin-piperaquine.  Peripheral blood parasite densities were measured until parasites cleared and then weekly to 63 days.  The primary outcome was recrudescent P falciparum parasitemia within 63 days.  We measured piperaquine plasma concns. at baseline, 7 days, and day of recrudescence.  We assessed phenotypic and genotypic markers of drug resistance in parasite isolates.  The study is registered with ClinicalTrials.gov, no. NCT01736319.  Between Sept 4, 2012, and Dec 31, 2013, we enrolled 241 participants.  In Pursat, where artemisinin resistance is entrenched, 37 (46%) of 81 patients had parasite recrudescence.  In Preah Vihear, where artemisinin resistance is emerging, ten (16%) of 63 patients had recrudescence and in Ratanakiri, where artemisinin resistance is rare, one (2%) of 60 patients did.  Patients with recrudescent P falciparum infections were more likely to have detectable piperaquine plasma concns. at baseline compared with non-recrudescent patients, but did not differ significantly in age, initial parasite d., or piperaquine plasma concns. at 7 days.  Recrudescent parasites had a higher prevalence of kelch13 mutations, higher piperaquine 50% inhibitory concn. (IC50) values, and lower mefloquine IC50 values; none had multiple pfmdr1 copies, a genetic marker of mefloquine resistance.  Dihydroartemisinin-piperaquine failures are caused by both artemisinin and piperaquine resistance, and commonly occur in places where dihydroartemisinin-piperaquine has been used in the private sector.  In Cambodia, artesunate plus mefloquine may be a viable option to treat dihydroartemisinin-piperaquine failures, and a more effective first-line ACT in areas where dihydroartemisinin-piperaquine failures are common.  The use of single low-dose primaquine to eliminate circulating gametocytes is needed in areas where artemisinin and ACT resistance is prevalent.  National Institute of Allergy and Infectious Diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0RSM1qQzR7Vg90H21EOLACvtfcHk0liB19EzxXx8TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D&md5=b2b62ae0ef4f2b67f7446a2a5718654d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900487-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DDek%26aufirst%3DD.%26aulast%3DTry%26aufirst%3DV.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DBlessborn%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTullo%26aufirst%3DG.%2BS.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26atitle%3DDihydroartemisinin%25E2%2580%2593Piperaquine%2520Resistance%2520in%2520Plasmodium%2520Falciparum%2520Malaria%2520in%2520Cambodia%253A%2520A%2520Multisite%2520Prospective%2520Cohort%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D357%26epage%3D365%26doi%3D10.1016%2FS1473-3099%2815%2900487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, D.</span><span> </span><span class="NLM_article-title">A Molecular Marker of Artemisinin-Resistant Plasmodium Falciparum Malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+Molecular+Marker+of+Artemisinin-Resistant+Plasmodium+Falciparum+Malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eYjAvrBdER3Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520Molecular%2520Marker%2520of%2520Artemisinin-Resistant%2520Plasmodium%2520Falciparum%2520Malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Dogovski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chotivanich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozdech, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klonis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, L.</span><span> </span><span class="NLM_article-title">Targeting the Cell Stress Response of Plasmodium Falciparum to Overcome Artemisinin Resistance</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002132</span><span class="refDoi"> DOI: 10.1371/journal.pbio.1002132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1371%2Fjournal.pbio.1002132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=25901609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=e1002132&author=C.+Dogovskiauthor=S.+C.+Xieauthor=G.+Burgioauthor=J.+Bridgfordauthor=S.+Mokauthor=J.+M.+McCawauthor=K.+Chotivanichauthor=S.+Kennyauthor=N.+Gn%C3%A4digauthor=J.+Straimerauthor=Z.+Bozdechauthor=D.+A.+Fidockauthor=J.+A.+Simpsonauthor=A.+M.+Dondorpauthor=S.+Footeauthor=N.+Klonisauthor=L.+Tilley&title=Targeting+the+Cell+Stress+Response+of+Plasmodium+Falciparum+to+Overcome+Artemisinin+Resistance&doi=10.1371%2Fjournal.pbio.1002132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance</span></div><div class="casAuthors">Dogovski, Con; Xie, Stanley C.; Burgio, Gaetan; Bridgford, Jess; Mok, Sachel; McCaw, James M.; Chotivanich, Kesinee; Kenny, Shannon; Gnadig, Nina; Straimer, Judith; Bozdech, Zbynek; Fidock, David A.; Simpson, Julie A.; Dondorp, Arjen M.; Foote, Simon; Klonis, Nectarios; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1002132/1-e1002132/26</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Successful control of falciparum malaria depends greatly on treatment with artemisinin combination therapies.  Thus, reports that resistance to artemisinins (ARTs) has emerged, and that the prevalence of this resistance is increasing, are alarming.  ART resistance has recently been linked to mutations in the K13 propeller protein.  The authors undertook a detailed kinetic anal. of the drug responses of K13 wild-type and mutant isolates of Plasmodium falciparum sourced from a region in Cambodia (Pailin).  They demonstrate that ART treatment induces growth retardation and an accumulation of ubiquitinated proteins, indicative of a cellular stress response that engages the ubiquitin/proteasome system.  They show that resistant parasites exhibit lower levels of ubiquitinated proteins and delayed onset of cell death, indicating an enhanced cell stress response.  The stress response could be targeted by inhibiting the proteasome.  Accordingly, clin. used proteasome inhibitors strongly synergize ART activity against both sensitive and resistant parasites, including isogenic lines expressing mutant or wild-type K13.  Synergy is also obsd. against Plasmodium berghei in vivo.  The authors developed a detailed model of parasite responses that enabled them to infer in vivo parasite clearance profiles from in vitro assessments of ART sensitivity.  They provide evidence that the clin. marker of resistance (delayed parasite clearance) is an indirect measure of drug efficacy because of the persistence of unviable parasites with unchanged morphol. in the circulation, and we suggest alternative approaches for the direct measurement of viability.  This model predicts that extending current three-day ART treatment courses to four days, or splitting the doses, will efficiently clear resistant parasite infections.  This work provides a rationale for improving the detection of ART resistance in the field and for treatment strategies that can be employed in areas with ART resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnq1k3owGeKbVg90H21EOLACvtfcHk0lhSUUMH2FTvnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVGqu7c%253D&md5=acb11e532b67d900a54958ceebee8db1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002132%26sid%3Dliteratum%253Aachs%26aulast%3DDogovski%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DBurgio%26aufirst%3DG.%26aulast%3DBridgford%26aufirst%3DJ.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DMcCaw%26aufirst%3DJ.%2BM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DKenny%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DJ.%2BA.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DFoote%26aufirst%3DS.%26aulast%3DKlonis%26aufirst%3DN.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520Cell%2520Stress%2520Response%2520of%2520Plasmodium%2520Falciparum%2520to%2520Overcome%2520Artemisinin%2520Resistance%26jtitle%3DPLoS%2520Biol.%26date%3D2015%26volume%3D13%26spage%3De1002132%26doi%3D10.1371%2Fjournal.pbio.1002132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannangelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klonis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, L.</span><span> </span><span class="NLM_article-title">Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium Falciparum Strains</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4501</span><span class="NLM_x">–</span> <span class="NLM_lpage">4510</span><span class="refDoi"> DOI: 10.1128/AAC.00574-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1128%2FAAC.00574-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=27161632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSis7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=4501-4510&author=T.+Yangauthor=S.+C.+Xieauthor=P.+Caoauthor=C.+Giannangeloauthor=J.+McCawauthor=D.+J.+Creekauthor=S.+A.+Charmanauthor=N.+Klonisauthor=L.+Tilley&title=Comparison+of+the+Exposure+Time+Dependence+of+the+Activities+of+Synthetic+Ozonide+Antimalarials+and+Dihydroartemisinin+against+K13+Wild-Type+and+Mutant+Plasmodium+Falciparum+Strains&doi=10.1128%2FAAC.00574-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the exposure time dependence of the activities of synthetic ozonide antimalarials and dihydroartemisinin against K13 wild-type and mutant Plasmodium falciparum strains</span></div><div class="casAuthors">Yang, Tuo; Xie, Stanley C.; Cao, Pengxing; Giannangelo, Carlo; McCaw, James; Creek, Darren J.; Charman, Susan A.; Klonis, Nectarios; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4501-4510</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Fully synthetic endoperoxide antimalarials, namely, OZ277 (RBx11160; also known as arterolane) and OZ439 (artefenomel), have been approved for marketing or are currently in clin. development.  We undertook an anal. of the kinetics of the in vitro responses of Plasmodium falciparum to the new ozonide antimalarials.  For these studies we used a K13 mutant (artemisinin resistant) isolate from a region in Cambodia and a genetically matched (artemisinin sensitive) K13 revertant.  We used a pulsed-exposure assay format to interrogate the time dependence of the response.  Because the ozonides have physicochem. properties different from those of the artemisinins, assay optimization was required to ensure that the drugs were completely removed following the pulsed exposure.  Like that of artemisinins, ozonide activity requires active Hb degrdn.  Short pulses of the ozonides were less effective than short pulses of dihydroartemisinin; however, when early-ring-stage parasites were exposed to drugs for periods relevant to their in vivo exposure, the ozonide antimalarials were markedly more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdXqYkFnGmlbVg90H21EOLACvtfcHk0lhSUUMH2FTvnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSis7zP&md5=390e3f479b4a3a953d550293ec91fcaf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.00574-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00574-16%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DGiannangelo%26aufirst%3DC.%26aulast%3DMcCaw%26aufirst%3DJ.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKlonis%26aufirst%3DN.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DComparison%2520of%2520the%2520Exposure%2520Time%2520Dependence%2520of%2520the%2520Activities%2520of%2520Synthetic%2520Ozonide%2520Antimalarials%2520and%2520Dihydroartemisinin%2520against%2520K13%2520Wild-Type%2520and%2520Mutant%2520Plasmodium%2520Falciparum%2520Strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D4501%26epage%3D4510%26doi%3D10.1128%2FAAC.00574-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00172</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1128/mBio.00172-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1128%2FmBio.00172-17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e00172-17&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+H.+Stokesauthor=M.+Ehrenbergerauthor=A.+A.+Craneauthor=D.+A.+Fidock&title=Plasmodium+falciparum+K13+Mutations+Differentially+Impact+Ozonide+Susceptibility+and+Parasite+Fitness&doi=10.1128%2FmBio.00172-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.00172-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00172-17%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3DEhrenberger%26aufirst%3DM.%26aulast%3DCrane%26aufirst%3DA.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPlasmodium%2520falciparum%2520K13%2520Mutations%2520Differentially%2520Impact%2520Ozonide%2520Susceptibility%2520and%2520Parasite%2520Fitness%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26spage%3De00172%26epage%3D17%26doi%3D10.1128%2FmBio.00172-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Baumgärtner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span> </span><span class="NLM_article-title">In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="refDoi"> DOI: 10.1186/s12936-017-1696-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1186%2Fs12936-017-1696-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=28122617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A280%3ADC%252BC1c7pt1Gnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=45&author=F.+Baumg%C3%A4rtnerauthor=J.+Jourdanauthor=C.+Scheurerauthor=B.+Blascoauthor=B.+Campoauthor=P.+M%C3%A4serauthor=S.+Wittlin&title=In+vitro+activity+of+anti-malarial+ozonides+against+an+artemisinin-resistant+isolate&doi=10.1186%2Fs12936-017-1696-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate</span></div><div class="casAuthors">Baumgartner Fabian; Jourdan Joelle; Scheurer Christian; Maser Pascal; Wittlin Sergio; Baumgartner Fabian; Jourdan Joelle; Scheurer Christian; Maser Pascal; Wittlin Sergio; Blasco Benjamin; Campo Brice</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recently published data suggest that artemisinin derivatives and synthetic peroxides, such as the ozonides OZ277 and OZ439, have a similar mode of action.  Here the cross-resistance of OZ277 and OZ439 and four additional next-generation ozonides was probed against the artemisinin-resistant clinical isolate Plasmodium falciparum Cam3.I, which carries the K13-propeller mutation R539T (Cam3.I(R539T)).  METHODS:  The previously described in vitro ring-stage survival assay (RSA0-3h) was employed and a simplified variation of the original protocol was developed.  RESULTS:  At the pharmacologically relevant concentration of 700 nM, all six ozonides were highly effective against the dihydroartemisinin-resistant P. falciparum Cam3.I(R539T) parasites, showing a per cent survival ranging from <0.01 to 1.83%.  A simplified version of the original RSA0-3h method was developed and gave similar results, thus providing a practical drug discovery tool for further optimization of next-generation anti-malarial peroxides.  CONCLUSION:  The absence of in vitro cross-resistance against the artemisinin-resistant clinical isolate Cam3.I(R539T) suggests that ozonides could be effective against artemisinin-resistant P. falciparum.  How this will translate to the human situation in clinical settings remains to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT81D1FD4aMH-kdrW1FkXG-fW6udTcc2eZfu1-RRvvJcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7pt1Gnsg%253D%253D&md5=3ef0b5011d7a16980762522cd3f65926</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-1696-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-1696-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumg%25C3%25A4rtner%26aufirst%3DF.%26aulast%3DJourdan%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520activity%2520of%2520anti-malarial%2520ozonides%2520against%2520an%2520artemisinin-resistant%2520isolate%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D45%26doi%3D10.1186%2Fs12936-017-1696-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Creek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCullough, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Iron-Mediated Degradation Kinetics of Substituted Dispiro-1,2,4-Trioxolane Antimalarials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">2956</span><span class="refDoi"> DOI: 10.1002/jps.20958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fjps.20958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=17549767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2945-2956&author=D.+Creekauthor=W.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=K.+J.+McCulloughauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Iron-Mediated+Degradation+Kinetics+of+Substituted+Dispiro-1%2C2%2C4-Trioxolane+Antimalarials&doi=10.1002%2Fjps.20958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials</span></div><div class="casAuthors">Creek, Darren J.; Charman, William N.; Chiu, Francis C. K.; Prankerd, Richard J.; McCullough, Kevin J.; Dong, Yuxiang; Vennerstrom, Jonathan L.; Charman, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2945-2956</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The iron-mediated reactivity of various dispiro-1,2,4-trioxolanes was detd. by automated kinetic anal. under std. reaction conditions.  The active antimalarial compds. underwent peroxide bond cleavage by Fe(II) resulting in products indicative of carbon-centered radical formation.  The rate of reaction was heavily influenced by the presence of spiro-substituted adamantane and cyclohexane rings, and was also significantly affected by cyclohexane ring substitution.  Steric hindrance around the peroxide oxygen atoms appeared to be the major determinant of reaction rate, however polar substituents also affected reactivity by an independent mechanism.  A wide range of reaction rates was obsd. within this class of peroxide antimalarials, however iron-mediated reactivity did not directly correlate with in vitro antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbEl3gTAvtQbVg90H21EOLACvtfcHk0ljLdV2dqR-PwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzL&md5=7381da53247f1de3a3cf78b4b152694e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjps.20958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20958%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DMcCullough%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DIron-Mediated%2520Degradation%2520Kinetics%2520of%2520Substituted%2520Dispiro-1%252C2%252C4-Trioxolane%2520Antimalarials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2945%26epage%3D2956%26doi%3D10.1002%2Fjps.20958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship of an Ozonide Carboxylic Acid (OZ78) Against Fasciola Hepatica</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4223</span><span class="NLM_x">–</span> <span class="NLM_lpage">4233</span><span class="refDoi"> DOI: 10.1021/jm100226t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100226t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4223-4233&author=Q.+Zhaoauthor=M.+Vargasauthor=Y.+Dongauthor=L.+Zhouauthor=X.+Wangauthor=K.+Sriraghavanauthor=J.+Keiserauthor=J.+L.+Vennerstrom&title=Structure-Activity+Relationship+of+an+Ozonide+Carboxylic+Acid+%28OZ78%29+Against+Fasciola+Hepatica&doi=10.1021%2Fjm100226t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of an Ozonide Carboxylic Acid (OZ78) against Fasciola hepatica</span></div><div class="casAuthors">Zhao, Qingjie; Vargas, Mireille; Dong, Yuxiang; Zhou, Lin; Wang, Xiaofang; Sriraghavan, Kamaraj; Keiser, Jennifer; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4223-4233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we describe the SAR of ozonide carboxylic acid OZ78 (1) as the first part of our search for a trematocidal synthetic peroxide drug development candidate.  We found that relatively small structural changes to 1 resulted most commonly in loss of activity against Fasciola hepatica in vivo.  A spiroadamantane substructure and acidic functional group (or ester prodrug) were required for activity.  Of 26 new compds. administered at single 100 mg/kg oral doses to F. hepatica infected rats, 8 had statistically significant worm burden redns., 7 were partially curative, and 1 (acylsulfonamide 6) was completely curative and comparable to 1 in flukicidal efficacy.  This study also showed that the activity of 1 is peroxide-bond-dependent, suggesting that its flukicidal efficacy depends upon Hb digestion in F. hepatica.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1lLdePK_TXrVg90H21EOLACvtfcHk0ljMG4BoLNXu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWju74%253D&md5=e525e022c0adc026c10c5b69b6d3f8de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm100226t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100226t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DVargas%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520an%2520Ozonide%2520Carboxylic%2520Acid%2520%2528OZ78%2529%2520Against%2520Fasciola%2520Hepatica%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4223%26epage%3D4233%26doi%3D10.1021%2Fjm100226t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Vennerstrom, J. L.; Dong, Y.; Chollet, J.; Matile, H.; Padmanilayam, M.; Tang, Y.; Charman, W. N.</span><span> </span><span class="NLM_article-title">Spiro and Dispiro 1,2,4-trioxolane Antimalarials</span>. U.S. Patent 2004/0039008 A1, February 26,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+L.+Vennerstrom&author=Y.+Dong&author=J.+Chollet&author=H.+Matile&author=M.+Padmanilayam&author=Y.+Tang&author=W.+N.+Charman&title=Spiro+and+Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSpiro%2520and%2520Dispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yadav, G. C.; Dorwal, H. N.; Valavala, S.; Sharma, V. K.</span><span> </span><span class="NLM_article-title">A Process for the Preparation of Spiro and Dispiro 1,2,4-trioxolane Antimalarials</span>. PCT WO 2007/138435 A2, December 6,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+C.+Yadav&author=H.+N.+Dorwal&author=S.+Valavala&author=V.+K.+Sharma&title=A+Process+for+the+Preparation+of+Spiro+and+Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DG.%2BC.%26atitle%3DA%2520Process%2520for%2520the%2520Preparation%2520of%2520Spiro%2520and%2520Dispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5776</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span><span class="refDoi"> DOI: 10.1021/ol5028392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5028392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5776-5779&author=S.+D.+Fontaineauthor=A.+G.+Dipasqualeauthor=A.+R.+Renslo&title=Efficient+and+Stereocontrolled+Synthesis+of+1%2C2%2C4-Trioxolanes+Useful+for+Ferrous+Iron-Dependent+Drug+Delivery&doi=10.1021%2Fol5028392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span></div><div class="casAuthors">Fontaine, Shaun D.; DiPasquale, Antonio G.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5776-5779</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferrous iron-promoted redn. of a hindered peroxide bond underlies the antimalarial action of the 1,2,4-trioxane artemisinin and the 1,2,4-trioxolane arterolane.  In appropriately designed systems, a 1,2,4-trioxolane ring can serve as a trigger to realize ferrous iron-dependent and parasite-selective drug delivery, both in vitro and in vivo.  A stereocontrolled, expeditious (three steps), and efficient (67-71% overall yield) synthesis of 1,2,4-trioxolanes, e.g., I possessing the requisite 3'' substitution pattern that enables ferrous iron-dependent drug delivery is reported.  The key synthetic step involves a diastereoselective Griesbaum co-ozonolysis reaction to afford primarily products with a trans relationship between the 3'' substituent and the peroxide bridge, as confirmed by X-ray structural anal. of a 3''-substituted 4-nitrobenzoate analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRW_OGGkPS7Vg90H21EOLACvtfcHk0ljMG4BoLNXu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE&md5=960d52771a3c0b91d4fc3b07c2d4a0ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol5028392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5028392%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DDipasquale%26aufirst%3DA.%2BG.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DEfficient%2520and%2520Stereocontrolled%2520Synthesis%2520of%25201%252C2%252C4-Trioxolanes%2520Useful%2520for%2520Ferrous%2520Iron-Dependent%2520Drug%2520Delivery%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5776%26epage%3D5779%26doi%3D10.1021%2Fol5028392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shibasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span> </span><span class="NLM_article-title">Asymmetric Catalysis with Heterobimetallic Compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1002/anie.199712361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fanie.199712361" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=1236-1256&author=M.+Shibasakiauthor=H.+Sasaiauthor=T.+Arai&title=Asymmetric+Catalysis+with+Heterobimetallic+Compounds&doi=10.1002%2Fanie.199712361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.199712361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199712361%26sid%3Dliteratum%253Aachs%26aulast%3DShibasaki%26aufirst%3DM.%26aulast%3DSasai%26aufirst%3DH.%26aulast%3DArai%26aufirst%3DT.%26atitle%3DAsymmetric%2520Catalysis%2520with%2520Heterobimetallic%2520Compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1997%26volume%3D36%26spage%3D1236%26epage%3D1256%26doi%3D10.1002%2Fanie.199712361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M.</span><span> </span><span class="NLM_article-title">A Catalytic Asymmetric Synthesis of Tubifolidine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7547</span><span class="NLM_x">–</span> <span class="NLM_lpage">7551</span><span class="refDoi"> DOI: 10.1021/jo981069g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo981069g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7547-7551&author=S.+Shimizuauthor=K.+Ohoriauthor=T.+Araiauthor=H.+Sasaiauthor=M.+Shibasaki&title=A+Catalytic+Asymmetric+Synthesis+of+Tubifolidine&doi=10.1021%2Fjo981069g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo981069g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981069g%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DOhori%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DSasai%26aufirst%3DH.%26aulast%3DShibasaki%26aufirst%3DM.%26atitle%3DA%2520Catalytic%2520Asymmetric%2520Synthesis%2520of%2520Tubifolidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7547%26epage%3D7551%26doi%3D10.1021%2Fjo981069g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M. A.</span><span> </span><span class="NLM_article-title">A Practical Large-Scale Synthesis of Enantiomerically Pure 3-[Bis(methoxycarbonyl)methyl]cyclohexanone via Catalytic Asymmetric Michael Reaction</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1016/S0040-4020(02)00141-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2FS0040-4020%2802%2900141-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2585-2588&author=Y.+Xuauthor=K.+Ohoriauthor=T.+Ohshimaauthor=M.+A.+Shibasaki&title=A+Practical+Large-Scale+Synthesis+of+Enantiomerically+Pure+3-%5BBis%28methoxycarbonyl%29methyl%5Dcyclohexanone+via+Catalytic+Asymmetric+Michael+Reaction&doi=10.1016%2FS0040-4020%2802%2900141-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900141-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900141-2%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DOhori%26aufirst%3DK.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DM.%2BA.%26atitle%3DA%2520Practical%2520Large-Scale%2520Synthesis%2520of%2520Enantiomerically%2520Pure%25203-%255BBis%2528methoxycarbonyl%2529methyl%255Dcyclohexanone%2520via%2520Catalytic%2520Asymmetric%2520Michael%2520Reaction%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2585%26epage%3D2588%26doi%3D10.1016%2FS0040-4020%2802%2900141-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tzvetkov, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmoldt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattay, J.</span><span> </span><span class="NLM_article-title">Synthesis of Optically Active (1R,4S,6S)-6-hydroxybicyclo[2.2.2]octan-2-One</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1016/j.tetasy.2006.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2Fj.tetasy.2006.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=993-998&author=N.+T.+Tzvetkovauthor=P.+Schmoldtauthor=B.+Neumannauthor=H.-G.+Stammlerauthor=J.+Mattay&title=Synthesis+of+Optically+Active+%281R%2C4S%2C6S%29-6-hydroxybicyclo%5B2.2.2%5Doctan-2-One&doi=10.1016%2Fj.tetasy.2006.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2006.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2006.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DSchmoldt%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DB.%26aulast%3DStammler%26aufirst%3DH.-G.%26aulast%3DMattay%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Optically%2520Active%2520%25281R%252C4S%252C6S%2529-6-hydroxybicyclo%255B2.2.2%255Doctan-2-One%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D993%26epage%3D998%26doi%3D10.1016%2Fj.tetasy.2006.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Riguet, E.</span><span> </span><span class="NLM_article-title">Novel Guanidinyl Pyrrolidine Salt-Based Bifunctional Organocatalysts: Application in Asymmetric Conjugate Addition of Malonates to Enones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4283</span><span class="NLM_x">–</span> <span class="NLM_lpage">4285</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1016%2Fj.tetlet.2009.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=4283-4285&author=E.+Riguet&title=Novel+Guanidinyl+Pyrrolidine+Salt-Based+Bifunctional+Organocatalysts%3A+Application+in+Asymmetric+Conjugate+Addition+of+Malonates+to+Enones&doi=10.1016%2Fj.tetlet.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DRiguet%26aufirst%3DE.%26atitle%3DNovel%2520Guanidinyl%2520Pyrrolidine%2520Salt-Based%2520Bifunctional%2520Organocatalysts%253A%2520Application%2520in%2520Asymmetric%2520Conjugate%2520Addition%2520of%2520Malonates%2520to%2520Enones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D4283%26epage%3D4285%26doi%3D10.1016%2Fj.tetlet.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wascholowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C. E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. V.</span><span> </span><span class="NLM_article-title">A General Organocatalytic Enantioselective Malonate Addition to α,β-Unsaturated Enones</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6155</span><span class="NLM_x">–</span> <span class="NLM_lpage">6165</span><span class="refDoi"> DOI: 10.1002/chem.200800673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1002%2Fchem.200800673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=18512863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVOgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6155-6165&author=V.+Wascholowskiauthor=K.+R.+Knudsenauthor=C.+E.+T.+Mitchellauthor=S.+V.+Ley&title=A+General+Organocatalytic+Enantioselective+Malonate+Addition+to+%CE%B1%2C%CE%B2-Unsaturated+Enones&doi=10.1002%2Fchem.200800673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A general organocatalytic enantioselective malonate addition to α,β-unsaturated enones</span></div><div class="casAuthors">Wascholowski, Veit; Knudsen, Kristian Rahbek; Mitchell, Claire E. T.; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6155-6165</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A general enantioselective organocatalytic conjugate addn. procedure of a variety of malonates to α,β-unsatd. enone systems is presented.  The reaction is efficiently catalyzed by the pyrrolidinyl tetrazole catalyst.  Cyclic, acyclic and arom. enones can be used and the reaction with Et malonates provides the Michael addn. products in high yields with good to excellent enantioselectivities.  Since only 1.5 equiv of malonate are used as a reagent, the reaction is readily scaled and practical to operate.  Furthermore, the malonate addn. products can be easily mono decarboxylated without loss in enantiomeric excess by enzymic or sodium hydroxide mediated methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp75lIycCnFprVg90H21EOLACvtfcHk0lgv1hgiBxY7JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVOgsbs%253D&md5=6da3d568b3f6505ed18fd76b53214869</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.200800673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200800673%26sid%3Dliteratum%253Aachs%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DKnudsen%26aufirst%3DK.%2BR.%26aulast%3DMitchell%26aufirst%3DC.%2BE.%2BT.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DA%2520General%2520Organocatalytic%2520Enantioselective%2520Malonate%2520Addition%2520to%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Enones%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D6155%26epage%3D6165%26doi%3D10.1002%2Fchem.200800673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Peters, W.</span> In  <span class="citation_source-book">Chemotherapy and Drug Resistance in Malaria</span>; <span class="NLM_publisher-name">Academic Press, Inc.</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">1987</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=145-273&author=W.+Peters&title=Chemotherapy+and+Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DW.%26btitle%3DChemotherapy%2520and%2520Drug%2520Resistance%2520in%2520Malaria%26pub%3DAcademic%2520Press%252C%2520Inc%26date%3D1987%26spage%3D145%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1021/jm901473s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901473s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=481-491&author=Y.+Dongauthor=S.+Wittlinauthor=K.+Sriraghavanauthor=J.+Cholletauthor=S.+A.+Charmanauthor=W.+N.+Charmanauthor=C.+Scheurerauthor=H.+Urwylerauthor=J.+Santo+Tomasauthor=C.+Snyderauthor=D.+J.+Creekauthor=J.+Morizziauthor=M.+Koltunauthor=H.+Matileauthor=X.+Wangauthor=M.+Padmanilayamauthor=Y.+Tangauthor=A.+Dornauthor=R.+Brunauthor=J.+L.+Vennerstrom&title=The+Structure-Activity+Relationship+of+the+Antimalarial+Ozonide+Arterolane+%28OZ277%29&doi=10.1021%2Fjm901473s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm901473s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901473s%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520Structure-Activity%2520Relationship%2520of%2520the%2520Antimalarial%2520Ozonide%2520Arterolane%2520%2528OZ277%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D481%26epage%3D491%26doi%3D10.1021%2Fjm901473s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Vennerstrom, J. L.; Dong, Y.; Charman, S. A.; Wittlin, S.; Chollet, J.; Creek, D. J.; Wang, X.; Sriraghavan, K.; Zhou, L.; Matile, H.; Charman, W. N.</span><span> </span><span class="NLM_article-title">Dispiro 1,2,4-trioxolane Antimalarials</span>. PCT WO 2009/058859 A2, May 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+L.+Vennerstrom&author=Y.+Dong&author=S.+A.+Charman&author=S.+Wittlin&author=J.+Chollet&author=D.+J.+Creek&author=X.+Wang&author=K.+Sriraghavan&author=L.+Zhou&author=H.+Matile&author=W.+N.+Charman&title=Dispiro+1%2C2%2C4-trioxolane+Antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DDispiro%25201%252C2%252C4-trioxolane%2520Antimalarials%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amewu, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pidathala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljayyoussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturén, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazaga, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirjanata, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noviyanti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marfurt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinden, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochford, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocken, C. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeeman, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span> </span><span class="NLM_article-title">A Tetraoxane-Based Antimalarial Drug Candidate That Overcomes PfK13-C580Y Dependent Artemisinin Resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15159</span><span class="refDoi"> DOI: 10.1038/ncomms15159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1038%2Fncomms15159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=28537265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15159&author=P.+M.+O%E2%80%99Neillauthor=R.+K.+Amewuauthor=S.+A.+Charmanauthor=S.+Sabbaniauthor=N.+F.+Gn%C3%A4digauthor=J.+Straimerauthor=D.+A.+Fidockauthor=E.+R.+Shoreauthor=N.+L.+Robertsauthor=M.+H.-L.+Wongauthor=W.+D.+Hongauthor=C.+Pidathalaauthor=C.+Rileyauthor=B.+Murphyauthor=G.+Aljayyoussiauthor=F.+J.+Gamoauthor=L.+Sanzauthor=J.+Rodriguesauthor=C.+G.+Cortesauthor=E.+Herrerosauthor=I.+Angulo-Bartur%C3%A9nauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+F.+Bazagaauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=B.+Campoauthor=R.+Sharmaauthor=E.+Ryanauthor=D.+M.+Shacklefordauthor=S.+Campbellauthor=D.+A.+Smithauthor=G.+Wirjanataauthor=R.+Noviyantiauthor=R.+N.+Priceauthor=J.+Marfurtauthor=M.+J.+Palmerauthor=I.+M.+Coppleauthor=A.+E.+Mercerauthor=A.+Rueckerauthor=M.+J.+Delvesauthor=R.+E.+Sindenauthor=P.+Sieglauthor=J.+Daviesauthor=R.+Rochfordauthor=C.+H.+M.+Kockenauthor=A.-M.+Zeemanauthor=G.+L.+Nixonauthor=G.+A.+Biaginiauthor=S.+A.+Ward&title=A+Tetraoxane-Based+Antimalarial+Drug+Candidate+That+Overcomes+PfK13-C580Y+Dependent+Artemisinin+Resistance&doi=10.1038%2Fncomms15159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance</span></div><div class="casAuthors">O'Neill, Paul M.; Amewu, Richard K.; Charman, Susan A.; Sabbani, Sunil; Gnadig, Nina F.; Straimer, Judith; Fidock, David A.; Shore, Emma R.; Roberts, Natalie L.; Wong, Michael H.-L.; Hong, W. David; Pidathala, Chandrakala; Riley, Chris; Murphy, Ben; Aljayyoussi, Ghaith; Gamo, Francisco Javier; Sanz, Laura; Rodrigues, Janneth; Cortes, Carolina Gonzalez; Herreros, Esperanza; Angulo-Barturen, Inigo; Jimenez-Diaz, Maria Belen; Bazaga, Santiago Ferrer; Martinez-Martinez, Maria Santos; Campo, Brice; Sharma, Raman; Ryan, Eileen; Shackleford, David M.; Campbell, Simon; Smith, Dennis A.; Wirjanata, Grennady; Noviyanti, Rintis; Price, Ric N.; Marfurt, Jutta; Palmer, Michael J.; Copple, Ian M.; Mercer, Amy E.; Ruecker, Andrea; Delves, Michael J.; Sinden, Robert E.; Siegl, Peter; Davies, Jill; Rochford, Rosemary; Kocken, Clemens H. M.; Zeeman, Anne-Marie; Nixon, Gemma L.; Biagini, Giancarlo A.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15159</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">K13 gene mutations are a primary marker of artemisinin resistance in Plasmodium falciparum malaria that threatens the long-term clin. utility of artemisinin-based combination therapies, the cornerstone of modern day malaria treatment.  Here we describe a multinational drug discovery program that has delivered a synthetic tetraoxane-based mol., E209, which meets key requirements of the Medicines for Malaria Venture drug candidate profiles.  E209 has potent nanomolar inhibitory activity against multiple strains of P. falciparum and P. vivax in vitro, is efficacious against P. falciparum in in vivo rodent models, produces parasite redn. ratios equiv. to dihydroartemisinin and has pharmacokinetic and pharmacodynamic characteristics compatible with a single-dose cure.  In vitro studies with transgenic parasites expressing variant forms of K13 show no cross-resistance with the C580Y mutation, the primary variant obsd. in Southeast Asia.  E209 is a superior next generation endoperoxide with combined pharmacokinetic and pharmacodynamic features that overcome the liabilities of artemisinin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy5gsI57-l8rVg90H21EOLACvtfcHk0lgf5LImABj4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12gsb8%253D&md5=652486b04d3bf715b07ccf76c6226db0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fncomms15159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15159%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DAmewu%26aufirst%3DR.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DSabbani%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DShore%26aufirst%3DE.%2BR.%26aulast%3DRoberts%26aufirst%3DN.%2BL.%26aulast%3DWong%26aufirst%3DM.%2BH.-L.%26aulast%3DHong%26aufirst%3DW.%2BD.%26aulast%3DPidathala%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DB.%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DC.%2BG.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DAngulo-Bartur%25C3%25A9n%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DBazaga%26aufirst%3DS.%2BF.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DA%2520Tetraoxane-Based%2520Antimalarial%2520Drug%2520Candidate%2520That%2520Overcomes%2520PfK13-C580Y%2520Dependent%2520Artemisinin%2520Resistance%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15159%26doi%3D10.1038%2Fncomms15159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sijwali, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span> </span><span class="NLM_article-title">Gene Disruption Confirms a Critical Role for the Cysteine Protease Falcipain-2 in Hemoglobin Hydrolysis by Plasmodium Falciparum</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4384</span><span class="NLM_x">–</span> <span class="NLM_lpage">4389</span><span class="refDoi"> DOI: 10.1073/pnas.0307720101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=10.1073%2Fpnas.0307720101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=15070727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4384-4389&author=P.+S.+Sijwaliauthor=P.+J.+Rosenthal&title=Gene+Disruption+Confirms+a+Critical+Role+for+the+Cysteine+Protease+Falcipain-2+in+Hemoglobin+Hydrolysis+by+Plasmodium+Falciparum&doi=10.1073%2Fpnas.0307720101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum</span></div><div class="casAuthors">Sijwali, Puran S.; Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4384-4389</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Erythrocytic malaria parasites degrade Hb in an acidic food vacuole to acquire free amino acids and maintain parasite homeostasis.  Hb hydrolysis appears to be a cooperative process requiring cysteine proteases (falcipains) and aspartic proteases (plasmepsins), but the specific roles of different enzymes in this process are unknown.  We previously showed that falcipain-2 is a major trophozoite food vacuole cysteine protease.  To characterize the specific role of falcipain-2, we disrupted the falcipain-2 gene and assessed the effect of this alteration.  Falcipain-2-knockout trophozoites had markedly diminished cysteine protease activity and swollen, dark staining food vacuoles, consistent with a block in Hb hydrolysis, as caused by cysteine protease inhibitors.  However, more mature stages of knockout parasites were indistinguishable from wild-type parasites and developed normally.  The knockout parasites had decreased and delayed expression of falcipain-2, which appeared to be directed by increased transcription of a 2nd copy of the gene (falcipain-2').  Expression of other falcipains and plasmepsins was similar in wild-type and knockout parasites.  Compared with wild-type, knockout parasites were ∼3-fold more sensitive to the cysteine protease inhibitors E-64 and leupeptin, and >50-fold more sensitive to the aspartic protease inhibitor pepstatin.  Our results assign a specific function for falcipain-2, the hydrolysis of Hb in trophozoites.  In addn., they highlight the cooperative action of cysteine and aspartic proteases in Hb degrdn. by malaria parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZW4wz_dvmZbVg90H21EOLACvtfcHk0lgf5LImABj4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKjur0%253D&md5=9e872338befb30d20d28da2fee29c729</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307720101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307720101%26sid%3Dliteratum%253Aachs%26aulast%3DSijwali%26aufirst%3DP.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DGene%2520Disruption%2520Confirms%2520a%2520Critical%2520Role%2520for%2520the%2520Cysteine%2520Protease%2520Falcipain-2%2520in%2520Hemoglobin%2520Hydrolysis%2520by%2520Plasmodium%2520Falciparum%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D4384%26epage%3D4389%26doi%3D10.1073%2Fpnas.0307720101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00699">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70375"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00699">10.1021/acs.jmedchem.7b00699</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedures and compound characterization for new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_001.pdf">jm7b00699_si_001.pdf (293.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00699/suppl_file/jm7b00699_si_002.csv">jm7b00699_si_002.csv (7.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00699&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00699%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00699" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                642KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a086c3b403d94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
